background	NN	ROOT
:	:	punct

patent	NN	compound
owner	NN	nsubj
file	VBD	ROOT
action	NN	dobj
against	IN	prep
competitor	NN	pobj
alleging	NN	pcomp
infringement	NN	dobj
.	.	punct

the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	ROOT
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
,	,	punct
Peter	NNP	compound
G.	NNP	compound
Sheridan	NNP	conj
,	,	punct
J.	NNP	appos
,	,	punct

2008	CD	nummod
WL	NNP	nsubj
628592	CD	nummod
,	,	punct
conclude	VBD	ROOT
that	IN	mark
patent	NN	nsubj
be	VBD	ccomp
invalid	JJ	acomp
due	IN	prep
to	IN	pcomp
obviousness	JJ	pobj
.	.	punct

Owner	NNP	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Mayer	NNP	conj
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
hold	VBD	advcl
that	DT	mark
innovation	NN	nsubj
to	TO	aux
micronize	VB	acl
drospirenone	NN	dobj
to	TO	aux
increase	VB	advcl
-PRON-	PRP$	poss
bioavailability	NN	dobj
,	,	punct
and	CC	cc
that	IN	mark
micronized	JJ	amod
drospirenone	NN	nsubj
would	MD	aux
absorb	VB	conj
with	IN	prep
normal	JJ	amod
pill	NN	pobj
,	,	punct
be	VBD	ROOT
obvious	JJ	acomp
.	.	punct

 	_SP	

Bayer	NNP	compound
Schering	NNP	compound
Pharma	NNP	compound
AG	NNP	nsubj
(	-LRB-	punct
"	``	punct
Bayer	NNP	appos
"	''	punct
)	-RRB-	punct
appeal	VBZ	ROOT
the	DT	det
judgment	NN	dobj
of	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
,	,	punct
hold	VBG	advcl
U.S.	NNP	compound
Patent	NNP	compound
No.	SYM	compound
6,787,531	CD	dobj
(	-LRB-	punct
"	``	punct
¡¬531	JJ	nummod
patent	NN	npadvmod
"	''	punct
)	-RRB-	punct
invalid	RB	ccomp
due	IN	prep
to	IN	pcomp
obviousness	JJ	pobj
.	.	punct

Bayer	NNP	compound
Schering	NNP	compound
Pharma	NNP	compound
AG	NNP	ROOT
v.	CC	prep
Barr	NNP	nmod
Labs.	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
No.	SYM	npadvmod
05-cv-2308	CD	nummod
,	,	punct

2008	CD	nummod
WL	NNP	ROOT
628592	CD	nummod
(	-LRB-	punct
D.N.J.	NNP	compound
March	NNP	appos
3	CD	nummod
,	,	punct
2008	CD	nummod
)	-RRB-	punct
.	.	punct

Because	IN	mark
-PRON-	PRP	nsubj
hold	VBP	advcl
that	IN	mark
the	DT	det
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
,	,	punct
-PRON-	PRP	nsubj
affirm	VBP	ROOT
.	.	punct

 	_SP	

Bayer	NNP	nsubj
be	VBZ	ROOT
a	DT	det
large	JJ	amod
pharmaceutical	JJ	amod
company	NN	attr
that	WDT	nsubj
produce	VBZ	relcl
the	DT	det
daily	JJ	amod
oral	JJ	amod
contraceptive	NN	dobj
,	,	punct
Yasmin	NNP	compound
(r)	SYM	appos
.	.	punct

one	CD	nsubj
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NNS	pobj
in	IN	prep
Yasmin	NNP	pobj
,	,	punct
drospirenone	NN	advcl
,	,	punct
be	VBZ	ROOT
a	DT	det
progestin	NN	attr
that	WDT	nsubj
inhibit	VBZ	relcl
ovulation	NN	dobj
.	.	punct

each	DT	nsubj
of	IN	prep
the	DT	det
invalidated	JJ	amod
claim	NNS	pobj
require	VBZ	ROOT
drospirenone	NN	xcomp
as	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
.	.	punct

drospirenone	NN	nsubjpass
be	VBD	auxpass
know	VBN	ROOT
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
all	DT	det
time	NNS	pobj
relevant	JJ	advcl
.	.	punct

-PRON-	PRP$	poss
contraceptive	JJ	amod
quality	NNS	nsubj
be	VBP	ROOT
particularly	RB	advmod
well	RB	advmod
suited	JJ	acomp
for	IN	prep
produce	VBG	pcomp
an	DT	det
oral	JJ	amod
contraceptive	NN	dobj
because	IN	mark
,	,	punct
in	IN	prep
addition	NN	pobj
to	IN	prep
inhibit	VBG	pcomp
ovulation	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	advcl
a	DT	det
diuretic	JJ	attr
which	WDT	nsubj
will	MD	aux
diminish	VB	ccomp
excess	JJ	amod
water	NN	compound
retention	NN	dobj
arise	VBG	acl
from	IN	prep
the	DT	det
estrogen	NN	compound
component	NN	pobj
of	IN	prep
oral	JJ	amod
contraceptive	NNS	pobj
,	,	punct
and	CC	cc
have	VBZ	conj
anti	JJ	subtok
-	JJ	subtok
acne	JJ	amod
quality	NNS	dobj
to	TO	aux
promote	VB	relcl
clear	JJ	amod
skin	NN	dobj
.	.	punct

These	DT	det
desirable	JJ	amod
quality	NNS	nsubj
have	VBP	aux
lead	VBN	ROOT
to	IN	prep
Yasmin	NNP	poss
's	POS	case
success	NN	pobj
.	.	punct

drospirenone	NN	nsubj
be	VBZ	ROOT
also	RB	advmod
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	acomp
.	.	punct

when	WRB	advmod
expose	VBN	advcl
to	IN	prep
low	JJ	pobj
-	HYPH	punct
ph	NN	nmod
(	-LRB-	punct
highly	RB	advmod
acidic	JJ	amod
)	-RRB-	punct
environment	NNS	pobj
such	JJ	amod
as	IN	prep
find	VBN	acl
in	IN	prep
the	DT	det
human	JJ	amod
stomach	NN	pobj
,	,	punct
drospirenone	NN	advcl
"	''	punct
isomerizes"-that	RB	nsubj
is	RB	ccomp
,	,	punct
the	DT	det
acid	NN	nsubj
catalyze	VBZ	ROOT
a	DT	det
reaction	NN	dobj
that	WDT	nsubj
rearrange	VBZ	relcl
drospirenone	NN	poss
's	POS	case
molecular	JJ	amod
structure	NN	dobj
while	IN	mark
-PRON-	PRP$	poss
molecular	JJ	amod
composition	NN	nsubj
remain	VBZ	advcl
constant	JJ	acomp
.	.	punct

the	DT	det
result	VBG	amod
isomer	NN	nsubj
be	VBZ	ROOT
non	JJ	subtok
-	JJ	subtok
antimineralocorticoidal	JJ	acomp
,	,	punct
mean	VBG	advcl
-PRON-	PRP	nsubj
will	MD	aux
not	RB	neg
act	VB	ccomp
as	IN	prep
a	DT	det
diuretic	JJ	pobj
,	,	punct
remove	VBG	advcl
the	DT	det
desirable	JJ	amod
anti	JJ	subtok
-	JJ	subtok
bloating	JJ	amod
effect	NN	dobj
that	WDT	nsubj
set	VBZ	relcl
drospirenone	NN	xcomp
apart	RB	advmod
from	IN	prep
other	JJ	amod
prior	JJ	amod
art	NN	compound
progestin	NNS	pobj
.	.	punct

therefore	RB	advmod
,	,	punct
scientist	NNS	nsubj
work	VBG	acl
with	IN	prep
drospirenone	NN	pobj
for	IN	prep
use	NN	pobj
in	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
must	MD	aux
be	VB	ROOT
aware	JJ	acomp
of	IN	prep
and	CC	cc
work	VB	conj
around	IN	prep
the	DT	det
effect	NNS	pobj
that	IN	dobj
the	DT	det
human	JJ	amod
stomach	NN	nsubj
will	MD	aux
have	VB	relcl
on	IN	prep
the	DT	det
drug	NN	pobj
to	TO	aux
ensure	VB	advcl
that	IN	mark
-PRON-	PRP$	poss
"	``	punct
bioavailability"-the	DT	det
amount	NN	nsubj
of	IN	prep
the	DT	det
active	JJ	amod
drug	NN	pobj
absorb	VBN	acl
into	IN	prep
the	DT	det
bloodstream	NN	pobj
and	CC	cc
available	JJ	conj
to	TO	aux
act	VB	xcomp
on	IN	prep
the	DT	det
body	NN	pobj
-	:	punct
be	VBZ	ccomp
high	JJ	acomp
enough	RB	advmod
to	TO	aux
perform	VB	xcomp
-PRON-	PRP$	poss
contraceptive	JJ	amod
function	NN	dobj
.	.	punct

 	_SP	

drospirenone	NN	nsubj
be	VBZ	ROOT
also	RB	advmod
a	DT	det
poorly	JJ	advmod
water	NN	nmod
soluble	JJ	amod
hydrophobic	NN	compound
composition	NN	attr
.	.	punct

Because	IN	mark
-PRON-	PRP	nsubj
will	MD	aux
not	RB	neg
easily	RB	advmod
dissolve	VB	advcl
into	IN	prep
a	DT	det
volume	NN	pobj
of	IN	prep
liquid	NN	pobj
,	,	punct
-PRON-	PRP$	poss
bioavailability	NN	nsubjpass
be	VBZ	auxpass
degrade	VBN	ROOT
.	.	punct

to	TO	aux
combat	VB	advcl
this	DT	dobj
,	,	punct
pharmaceutical	JJ	amod
producer	NNS	nsubj
commonly	RB	advmod
employ	VBP	ROOT
a	DT	det
technique	NN	dobj
call	VBN	acl
"	``	punct
micronization	NN	oprd
,	,	punct
"	''	punct
whereby	WRB	advmod
the	DT	det
drug	NN	poss
's	POS	case
particle	NN	compound
size	NN	nsubjpass
be	VBZ	auxpass
reduce	VBN	relcl
,	,	punct
increase	VBG	advcl
-PRON-	PRP$	poss
overall	JJ	amod
surface	NN	compound
area	NN	dobj
.	.	punct

often	RB	advmod
(	-LRB-	punct
but	CC	cc
not	RB	neg
always	RB	conj
)	-RRB-	punct
with	IN	prep
a	DT	det
large	JJR	amod
surface	NN	compound
area	NN	pobj
,	,	punct
the	DT	det
dissolution	NN	compound
rate	NN	nsubjpass
be	VBZ	auxpass
also	RB	advmod
increase	VBN	ROOT
,	,	punct
ensure	VBG	advcl
that	IN	mark
all	DT	nsubj
of	IN	prep
the	DT	det
poorly	JJ	advmod
water	NN	nmod
soluble	JJ	amod
drug	NN	pobj
that	WDT	nsubj
can	MD	aux
dissolve	VB	relcl
will	MD	aux
dissolve	VB	ccomp
in	IN	prep
a	DT	det
give	VBN	amod
volume	NN	pobj
of	IN	prep
liquid	NN	pobj
.	.	punct

With	IN	prep
more	JJR	pobj
of	IN	prep
the	DT	det
drug	NN	compound
dissolve	VBN	pobj
,	,	punct
the	DT	det
drug	NN	nsubj
will	MD	aux
exhibit	VB	ROOT
a	DT	det
high	JJR	amod
bioavailability	NN	dobj
.	.	punct

indeed	RB	advmod
,	,	punct
Bayer	NNP	poss
's	POS	case
expert	NN	nsubj
testify	VBD	ROOT
at	IN	prep
trial	NN	pobj
that	IN	mark
this	DT	nsubj
would	MD	aux
be	VB	ccomp
-PRON-	PRP$	poss
first	JJ	amod
choice	NN	attr
in	IN	prep
attempt	VBG	pcomp
to	TO	aux
increase	VB	xcomp
the	DT	det
dissolution	NN	compound
rate	NN	dobj
because	IN	mark
,	,	punct
among	IN	prep
the	DT	det
different	JJ	amod
way	NNS	pobj
to	TO	aux
increase	VB	relcl
the	DT	det
dissolution	NN	compound
rate	NN	dobj
,	,	punct
micronization	NN	nsubj
present	VBZ	advcl
the	DT	det
good	JJS	amod
chance	NN	dobj
of	IN	prep
success	NN	pobj
.	.	punct

all	DT	det
commercially	RB	advmod
available	JJ	amod
oral	JJ	amod
contraceptive	NNS	nsubj
use	VBP	ROOT
micronized	JJ	amod
progestin	NNS	dobj
and/or	CC	cc
estrogen	VBZ	conj
,	,	punct
so	CC	cc
this	DT	det
technique	NN	nsubj
be	VBD	conj
well	RB	advmod
know	VBN	acomp
in	IN	prep
the	DT	det
art	NN	pobj
.	.	punct

 	_SP	

While	IN	mark
micronize	VBG	csubj
a	DT	det
poorly	JJ	advmod
water	NN	nmod
soluble	JJ	amod
composition	NN	dobj
may	MD	aux
result	VB	ROOT
in	IN	prep
increase	VBN	amod
bioavailability	NN	pobj
,	,	punct
micronize	VBG	advcl
an	DT	det
acid	NN	compound
-	HYPH	punct
sensitive	JJ	amod
composition	NN	dobj
may	MD	aux
also	RB	advmod
increase	VB	conj
-PRON-	PRP$	poss
sensitivity	NN	dobj
to	IN	prep
the	DT	det
acid	NN	pobj
.	.	punct

a	DT	det
drug	NN	nsubj
that	WDT	nsubj
isomerize	VBZ	relcl
when	WRB	advmod
expose	VBN	advcl
to	IN	prep
acid	NN	pobj
thus	RB	advmod
may	MD	aux
isomerize	VB	ROOT
at	IN	prep
a	DT	det
fast	JJR	amod
rate	NN	pobj
if	IN	mark
-PRON-	PRP	nsubjpass
be	VBZ	auxpass
micronize	VBN	advcl
.	.	punct

 	_SP	

one	CD	nummod
method	NN	compound
pharmaceutical	NN	compound
company	NNS	nsubj
use	VBP	ROOT
to	TO	aux
surmount	VB	xcomp
an	DT	det
acid	NN	compound
-	HYPH	punct
sensitivity	NN	compound
problem	NN	dobj
with	IN	prep
a	DT	det
drug	NN	pobj
to	TO	aux
be	VB	auxpass
take	VBN	relcl
orally	RB	advmod
be	VBZ	conj
to	TO	aux
deliver	VB	xcomp
the	DT	det
drug	NN	dobj
via	IN	prep
an	DT	det
enteric	JJ	amod
-	HYPH	punct
coated	JJ	amod
pill	NN	pobj
,	,	punct
as	IN	mark
oppose	VBN	advcl
to	IN	prep
an	DT	det
immediate	JJ	amod
release	NN	compound
pill	NN	pobj
,	,	punct
also	RB	advmod
call	VBD	conj
a	DT	det
"	``	punct
normal	JJ	amod
pill	NN	oprd
"	''	punct
.	.	punct

an	DT	det
enteric	JJ	amod
coating	NN	nsubj
be	VBZ	ROOT
a	DT	det
ph	NN	subtok
-	HYPH	subtok
sensitive	JJ	amod
film	NN	attr
that	WDT	nsubj
protect	VBZ	relcl
the	DT	det
drug	NN	dobj
from	IN	prep
stomach	NN	compound
acid	NN	pobj
,	,	punct
and	CC	cc
only	RB	advmod
release	VBZ	conj
the	DT	det
drug	NN	dobj
when	WRB	advmod
-PRON-	PRP	nsubj
have	VBZ	aux
pass	VBN	advcl
into	IN	prep
the	DT	det
less	RBR	advmod
acidic	JJ	amod
duodenum	NN	amod
and	CC	cc
small	JJ	conj
intestine	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
enteric	JJ	amod
coating	NNS	nsubj
be	VBP	ROOT
not	RB	neg
without	IN	prep
drawback	NNS	pcomp
-PRON-	PRP	npadvmod
.	.	punct

coated	JJ	amod
tablet	NNS	nsubj
include	VBG	prep
enteric	JJ	amod
coated	JJ	amod
tablet	NNS	pobj
present	VBP	ROOT
an	DT	det
obstacle	NN	dobj
to	IN	prep
absorption	NN	pobj
,	,	punct
and	CC	cc
thus	RB	advmod
reduce	VB	conj
the	DT	det
drug	NN	poss
's	POS	case
exhibit	VBN	amod
bioavailability	NN	dobj
.	.	punct

additionally	RB	advmod
,	,	punct
as	IN	mark
be	VBD	auxpass
know	VBN	advcl
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
introduce	VBP	ROOT
a	DT	det
significant	JJ	amod
delay	NN	dobj
in	IN	prep
the	DT	det
onset	NN	pobj
of	IN	prep
therapeutic	JJ	amod
response	NN	pobj
while	IN	mark
create	VBG	advcl
a	DT	det
considerable	JJ	amod
patient	NN	nmod
-	HYPH	punct
to	IN	prep
-	HYPH	punct
patient	JJ	pobj
variation	NN	dobj
of	IN	prep
that	DT	det
onset	NN	pobj
.	.	punct

In	IN	prep
fact	NN	pobj
,	,	punct
even	RB	advmod
for	IN	prep
an	DT	det
individual	NN	pobj
take	VBG	acl
the	DT	det
drug	NN	dobj
at	IN	prep
different	JJ	amod
time	NNS	pobj
,	,	punct
the	DT	det
response	NN	compound
time	NN	nsubj
may	MD	aux
vary	VB	ROOT
considerably	RB	advmod
from	IN	prep
dose	NN	pobj
to	IN	prep
dose	NN	pobj
.	.	punct

bayer	NN	compound
scientist	NNS	nsubj
notice	VBD	ROOT
these	DT	det
intra	JJ	nmod
-	HYPH	punct
and	CC	cc
inter	JJ	subtok
-	JJ	subtok
individual	JJ	conj
bioavailability	NN	compound
difference	NNS	dobj
in	IN	prep
practice	NN	pobj
in	IN	prep
-PRON-	PRP$	poss
study	NNS	pobj
on	IN	prep
beagle	NNS	pobj
and	CC	cc
woman	NNS	conj
.	.	punct

This	DT	nsubj
present	VBD	ROOT
a	DT	det
further	JJ	amod
complication	NN	dobj
because	IN	mark
Bayer	NNP	nsubj
require	VBD	advcl
the	DT	det
drug	NN	dobj
to	TO	aux
be	VB	xcomp
99	CD	nummod
%	NN	npadvmod
effective	JJ	acomp
,	,	punct
and	CC	cc
work	VB	nsubj
on	IN	prep
all	DT	det
woman	NNS	pobj
at	IN	prep
a	DT	det
single	JJ	amod
dose-"one	NN	compound
dose	NN	pobj
must	MD	aux
fit	VB	conj
all	DT	dobj
"	''	punct
.	.	punct

a	DT	det
normal	JJ	amod
pill	NN	nsubj
may	MD	aux
not	RB	neg
present	VB	ROOT
such	JJ	amod
variation	NNS	dobj
,	,	punct
but	CC	cc
will	MD	aux
expose	VB	conj
-PRON-	PRP$	poss
content	NNS	dobj
to	IN	prep
the	DT	det
stomach	NN	poss
's	POS	case
highly	RB	advmod
acidic	JJ	amod
environment	NN	pobj
.	.	punct

 	_SP	

Dr.	NNP	compound
Johannes	NNP	compound
Tack	NNP	nsubj
,	,	punct
a	DT	det
Bayer	NNP	compound
scientist	NN	appos
,	,	punct
begin	VBD	ROOT
work	NN	dobj
in	IN	prep
1983	CD	pobj
to	TO	aux
develop	VB	xcomp
drospirenone	NN	dobj
into	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
.	.	punct

At	IN	prep
the	DT	det
time	NN	pobj
,	,	punct
Bayer	NNP	nsubj
have	VBD	aux
be	VBN	aux
work	VBG	ROOT
with	IN	prep
a	DT	det
relate	VBN	amod
compound	NN	pobj
,	,	punct
spirorenone	NN	appos
,	,	punct
as	IN	prep
a	DT	det
diuretic	JJ	pobj
.	.	punct

when	WRB	advmod
consume	VBN	advcl
,	,	punct
spirorenone	NN	amod
metabolize	NNS	ROOT
into	IN	prep
drospirenone	NN	pobj
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
still	RB	advmod
a	DT	det
diuretic	JJ	attr
,	,	punct
but	CC	cc
be	VBD	auxpass
find	VBN	conj
to	TO	aux
have	VB	xcomp
progestogenic	NN	amod
(	-LRB-	punct
contraceptive	NN	amod
)	-RRB-	punct
effect	NNS	dobj
.	.	punct

Spirorenone	VBN	nsubj
-PRON-	PRP	appos
have	VBD	ROOT
some	DT	det
contraceptive	JJ	amod
effect	NNS	nsubj
that	WDT	nsubj
Bayer	NNP	nsubj
conclude	VBD	relcl
be	VBD	ccomp
the	DT	det
result	NN	attr
of	IN	prep
the	DT	det
appearance	NN	pobj
of	IN	prep
drospirenone	NN	pobj
when	WRB	advmod
-PRON-	PRP	nsubj
metabolize	VBD	advcl
.	.	punct

Bayer	NNP	nsubj
decide	VBD	ROOT
to	TO	aux
harness	VB	xcomp
the	DT	det
diuretic	JJ	amod
effect	NN	dobj
of	IN	prep
isolated	JJ	amod
drospirenone	NN	pobj
to	TO	aux
create	VB	advcl
the	DT	det
new	JJ	amod
contraceptive	NN	dobj
.	.	punct

tack	NN	nsubj
consult	VBD	ROOT
prior	JJ	advmod
Bayer	NNP	compound
work	NN	dobj
with	IN	prep
drospirenone	NN	pobj
include	VBG	prep
in	IN	prep
vitro	FW	amod
isomerization	NN	compound
study	NNS	pobj
perform	VBN	acl
by	IN	agent
a	DT	det
fellow	JJ	amod
Bayer	NNP	compound
scientist	NN	pobj
,	,	punct
Dr.	NNP	compound
Werner	NNP	compound
Krause	NNP	appos
.	.	punct

Krause	NNP	nsubj
have	VBD	aux
also	RB	advmod
perform	VBN	ROOT
in	IN	prep
vivo	NNS	compound
study	NNS	pobj
with	IN	prep
spirorenone	NN	pobj
,	,	punct
about	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
publish	VBD	relcl
three	CD	nummod
article	NNS	dobj
.	.	punct

These	DT	det
study	NNS	nsubj
,	,	punct
Krause	NNP	compound
I	NNP	appos
,	,	punct
II	NNP	conj
,	,	punct
and	CC	cc
III	NNP	conj
,	,	punct
include	VBD	ROOT
the	DT	det
knowledge	NN	dobj
that	WDT	nsubj
drospirenone	NN	relcl
be	VBD	acl
a	DT	det
metabolite	NN	attr
of	IN	prep
spirorenone	NN	pobj
.	.	punct

Tack	NNP	nsubj
decide	VBD	ROOT
,	,	punct
however	RB	advmod
,	,	punct
that	IN	mark
these	DT	nsubj
in	IN	prep
vivo	NNS	compound
study	NNS	pobj
garner	VBD	ccomp
little	JJ	amod
information	NN	dobj
on	IN	prep
the	DT	det
practice	NN	pobj
of	IN	prep
drospirenone	NN	pobj
in	IN	prep
vivo	NNS	pobj
.	.	punct

 	_SP	

Tack	NNP	nsubj
test	VBD	ROOT
the	DT	det
stability	NN	dobj
of	IN	prep
drospirenone	NN	pobj
in	IN	prep
acid	NN	pobj
at	IN	prep
pH	NNS	pobj
1	CD	nummod
to	TO	aux
simulate	VB	advcl
the	DT	det
condition	NNS	dobj
of	IN	prep
the	DT	det
stomach	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
find	VBD	ROOT
that	IN	mark
after	IN	prep
10	CD	nummod
minute	NNS	pobj
,	,	punct
21	CD	nummod
%	NN	nsubj
of	IN	prep
the	DT	det
drospirenone	NN	pobj
have	VBD	aux
isomerize	VBN	ccomp
in	IN	prep
the	DT	det
acid	NN	pobj
,	,	punct
and	CC	cc
after	IN	prep
45	CD	nummod
minute	NNS	pobj
,	,	punct
half	NN	nsubj
have	VBD	aux
isomerize	VBN	conj
.	.	punct

-PRON-	PRP	nsubj
come	VBD	ROOT
to	IN	prep
a	DT	det
critical	JJ	amod
conclusion	NN	pobj
:	:	punct

 	_SP	

If	IN	mark
the	DT	det
result	NNS	nsubjpass
obtain	VBN	acl
in	IN	prep
vitro	NN	pobj
be	VBP	auxpass
apply	VBN	advcl
to	IN	prep
in	IN	prep
vivo	NNS	compound
condition	NNS	pobj
,	,	punct
-PRON-	PRP	nsubjpass
can	MD	aux
be	VB	auxpass
presume	VBN	ROOT
that	IN	mark
,	,	punct
with	IN	prep
an	DT	det
assume	VBN	amod
gastric	JJ	amod
juice	NN	compound
volume	NN	pobj
of	IN	prep
100ml	NNP	pobj
,	,	punct
the	DT	det
majority	NN	nsubj
of	IN	prep
the	DT	det
dose	NN	pobj
(	-LRB-	punct
solubility	NN	appos
of	IN	prep
drospirenone	NN	pobj
5	CD	nummod
-	SYM	punct
10	CD	nummod
mg	NN	nmod
/	SYM	punct
l	NN	punct
)	-RRB-	punct
pass	VBZ	ccomp
into	IN	prep
solution	NN	pobj
during	IN	prep
passage	NN	pobj
through	IN	prep
the	DT	det
stomach	NN	pobj
and	CC	cc
consequently	RB	advmod
undergoe	NNS	amod
rapid	JJ	amod
isomerization	NN	conj
.	.	punct

a	DT	det
clear	JJ	amod
reduction	NN	nsubj
in	IN	prep
the	DT	det
bioavailability	NN	pobj
of	IN	prep
the	DT	det
unchanged	JJ	amod
active	JJ	amod
substance	NN	pobj
be	VBZ	ROOT
to	TO	aux
be	VB	auxpass
expect	VBN	xcomp
as	IN	prep
a	DT	det
result	NN	pobj
.	.	punct

 	_SP	

the	DT	det
plan	VBN	amod
study	NNS	nsubjpass
on	IN	prep
the	DT	det
progestogenic	JJ	amod
efficacy	NN	pobj
of	IN	prep
[	-LRB-	punct
drospirenone	NN	pobj
]	-RRB-	punct
should	MD	aux
therefore	RB	advmod
be	VB	auxpass
perform	VBN	ROOT
with	IN	prep
an	DT	det
enteric	JJ	amod
-	HYPH	punct
coat	VBN	amod
formulation	NN	pobj
.	.	punct

 	_SP	

Tack	NNP	nsubj
then	RB	advmod
move	VBD	ROOT
into	IN	prep
clinical	JJ	amod
study	NNS	pobj
with	IN	prep
an	DT	det
enteric	JJ	amod
-	HYPH	punct
coat	VBN	amod
formulation	NN	pobj
of	IN	prep
drospirenone	NN	pobj
.	.	punct

For	IN	prep
five	CD	nummod
year	NNS	pobj
,	,	punct
Bayer	NNP	nsubj
use	VBD	ROOT
this	DT	det
coated	JJ	amod
pill	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
study	NNS	pobj
,	,	punct
even	RB	advmod
reconfirm	VBG	advcl
in	IN	prep
1988	CD	pobj
that	IN	nsubj
drospirenone	NN	nsubj
need	VBD	ccomp
an	DT	det
enteric	JJ	amod
coating	NN	dobj
because	IN	mark
-PRON-	PRP	nsubj
isomerize	VBD	advcl
quickly	RB	advmod
in	IN	prep
a	DT	det
ph	XX	nmod
1	CD	nummod
acidic	JJ	amod
solution	NN	pobj
.	.	punct

 	_SP	

In	IN	prep
1988	CD	pobj
,	,	punct
Bayer	NNP	nsubj
also	RB	advmod
plan	VBD	ROOT
a	DT	det
study	NN	dobj
to	TO	aux
determine	VB	acl
how	WRB	advmod
effectively	RB	advmod
-PRON-	PRP$	poss
enteric	JJ	amod
-	HYPH	punct
coated	JJ	amod
tablet	NN	nsubj
deliver	VBD	ccomp
a	DT	det
formulation	NN	dobj
as	IN	mark
compare	VBN	advcl
to	IN	prep
an	DT	det
intravenous	JJ	amod
injection	NN	pobj
of	IN	prep
the	DT	det
same	JJ	amod
formulation	NN	pobj
.	.	punct

This	DT	det
study	NN	nsubj
would	MD	aux
thus	RB	advmod
measure	VB	ROOT
the	DT	det
"	``	punct
absolute	JJ	amod
bioavailability	NN	dobj
"	''	punct
of	IN	prep
the	DT	det
drug	NN	pobj
.	.	punct

Bayer	NNP	nsubj
add	VBD	ROOT
what	WP	attr
-PRON-	PRP	nsubj
term	VBZ	ccomp
a	DT	det
"	``	punct
non	JJ	subtok
-	JJ	subtok
routine	JJ	amod
"	''	punct
element	NN	dobj
to	IN	prep
the	DT	det
study	NN	pobj
,	,	punct
by	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
add	VBD	relcl
an	DT	det
unprotected	JJ	amod
(	-LRB-	punct
normal	JJ	pobj
)	-RRB-	punct
drospirenone	NN	dobj
tablet	NN	dobj
and	CC	cc
compare	VBD	conj
-PRON-	PRP$	poss
bioavailability	NN	dobj
to	IN	prep
that	DT	pobj
of	IN	prep
the	DT	det
enteric	RB	amod
-	HYPH	punct
coat	VBN	amod
formulation	NN	pobj
and	CC	cc
the	DT	det
intravenous	JJ	amod
delivery	NN	conj
.	.	punct

Tack	NNP	nsubj
expect	VBD	ROOT
to	TO	aux
find	VB	xcomp
that	IN	mark
the	DT	det
enteric	RB	amod
-	HYPH	punct
coated	JJ	amod
tablet	NN	nsubj
would	MD	aux
produce	VB	ccomp
a	DT	det
low	JJR	amod
bioavailability	NN	dobj
than	IN	prep
an	DT	det
intravenous	JJ	amod
injection	NN	pobj
,	,	punct
while	IN	mark
the	DT	det
normal	JJ	amod
pill	NN	nsubj
would	MD	aux
produce	VB	advcl
an	DT	det
even	RB	advmod
low	JJR	amod
bioavailability	NN	dobj
than	IN	prep
the	DT	det
enteric	RB	amod
-	HYPH	punct
coated	JJ	amod
tablet	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
find	VBD	ROOT
that	IN	mark
despite	IN	prep
-PRON-	PRP$	poss
observation	NNS	pobj
that	WDT	det
drospirenone	NN	nsubj
would	MD	aux
quickly	RB	advmod
isomerize	VB	ccomp
in	IN	prep
a	DT	det
highly	RB	advmod
acidic	JJ	amod
environment	NN	pobj
and	CC	cc
-PRON-	PRP$	poss
belief	NN	conj
therefore	RB	advmod
that	IN	mark
an	DT	det
enteric	JJ	amod
coating	NN	nsubj
would	MD	aux
be	VB	advcl
necessary	JJ	acomp
to	TO	aux
preserve	VB	advcl
bioavailability	NN	dobj
,	,	punct
the	DT	det
normal	JJ	amod
pill	NN	nsubj
and	CC	cc
the	DT	det
enteric	JJ	npadvmod
-	HYPH	punct
coated	JJ	amod
pill	NN	conj
result	VBD	conj
in	IN	prep
the	DT	det
same	JJ	amod
bioavailability	NN	pobj
.	.	punct

follow	VBG	prep
this	DT	det
study	NN	pobj
,	,	punct
Bayer	NNP	nsubj
develop	VBD	ROOT
drospirenone	NN	dobj
in	IN	prep
a	DT	det
normal	JJ	amod
pill	NN	pobj
,	,	punct
for	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
would	MD	aux
eventually	RB	advmod
receive	VB	relcl
the	DT	det
¡¬531	JJ	nummod
patent	NN	dobj
.	.	punct

 	_SP	

Bayer	NNP	nsubj
rely	VBD	ROOT
on	IN	prep
the	DT	det
finding	NN	pobj
that	DT	mark
drospirenone	NN	nsubj
would	MD	aux
absorb	VB	relcl
with	IN	prep
a	DT	det
normal	JJ	amod
pill	NN	pobj
to	TO	aux
overcome	VB	advcl
an	DT	det
obviousness	JJ	amod
rejection	NN	dobj
in	IN	prep
the	DT	det
patent	NN	nmod
and	CC	cc
Trademark	NNP	conj
Office	NNP	pobj
.	.	punct

during	IN	prep
prosecution	NN	pobj
,	,	punct
the	DT	det
examiner	NN	nsubj
reject	VBD	ROOT
the	DT	det
claim	NNS	dobj
as	RB	prep
obvious	JJ	amod
in	IN	prep
view	NN	pobj
of	IN	prep
a	DT	det
De	NNP	compound
Castro	NNP	compound
reference	NN	pobj
,	,	punct
which	WDT	nsubj
the	DT	det
examiner	NN	nsubj
say	VBD	relcl
teach	VBN	ccomp
to	TO	aux
micronize	VB	xcomp
poorly	RB	advmod
soluble	JJ	amod
drug	NNS	dobj
to	TO	aux
increase	VB	advcl
-PRON-	PRP$	poss
bioavailability	NN	dobj
.	.	punct

Bayer	NNP	nsubj
respond	VBD	ROOT
that	IN	mark
another	DT	det
piece	NN	nsubj
of	IN	prep
prior	JJ	amod
art	NN	pobj
,	,	punct
the	DT	det
Nickisch	NNP	compound
reference	NN	appos
,	,	punct
teach	VBD	ccomp
that	IN	mark
micronize	VBG	compound
drospirenone	NN	nsubj
would	MD	aux
increase	VB	ccomp
-PRON-	PRP$	poss
exposure	NN	dobj
to	IN	prep
the	DT	det
highly	RB	advmod
acidic	JJ	amod
environment	NN	pobj
in	IN	prep
the	DT	det
stomach	NN	pobj
,	,	punct
which	WDT	nsubj
would	MD	aux
result	VB	relcl
in	IN	prep
increase	VBN	amod
isomerization	NN	pobj
.	.	punct

the	DT	det
examiner	NN	nsubj
allow	VBD	ccomp
the	DT	det
claim	NNS	dobj
,	,	punct
give	VBG	advcl
the	DT	det
specific	JJ	amod
reason	NN	dobj
that	WDT	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
suggest	VBD	relcl
that	IN	mark
micronize	VBG	amod
drospirenone	NN	nsubj
would	MD	aux
not	RB	neg
work	VB	ccomp
:	:	punct
"	``	punct
the	DT	det
micronized	JJ	amod
drospirenone	NN	nsubjpass
will	MD	aux
be	VB	auxpass
degrade	VBN	ROOT
even	RB	advmod
more	RBR	advmod
rapidly	RB	advmod
because	IN	mark
the	DT	det
micronization	NN	nsubj
of	IN	prep
drospirenone	NN	compound
expose	JJ	pobj
[	-LRB-	punct
sic	NN	appos
]	-RRB-	punct
the	DT	det
drug	NN	compound
particle	NNS	appos
in	IN	prep
the	DT	det
stomach	NN	pobj
(	-LRB-	punct
acidic	JJ	advcl
)	-RRB-	punct
.	.	punct

therefore	RB	advmod
,	,	punct
to	TO	aux
formulate	VB	advcl
an	DT	det
oral	JJ	amod
dosage	NN	compound
form	NNS	dobj
[	-LRB-	punct
sic	NN	intj
]	-RRB-	punct
contain	VBG	advcl
the	DT	det
drospirenone	NN	compound
particle	NNS	dobj
,	,	punct
which	WDT	nsubj
expose	VBD	relcl
to	IN	prep
the	DT	det
gastric	JJ	amod
environment	NN	pobj
upon	IN	prep
dissolution	NN	pobj
,	,	punct
would	MD	aux
be	VB	ROOT
unobvious	JJ	acomp
in	IN	prep
view	NN	pobj
of	IN	prep
the	DT	det
datum	NNS	pobj
present	VBN	acl
....	.	punct
"	''	punct

 	_SP	
the	DT	det
¡¬531	JJ	nummod
patent	NN	attr
issue	VBN	acl
on	IN	prep
September	NNP	pobj
7	CD	nummod
,	,	punct
2004	CD	nummod
.	.	punct

Claim	NNP	nsubj
1	CD	nummod
be	VBZ	ROOT
representative	JJ	acomp
:	:	punct

 	_SP	

1	CD	ROOT
.	.	punct

a	DT	det
pharmaceutical	JJ	amod
composition	NN	ROOT
comprise	VBG	acl

 	_SP	
from	IN	prep
about	RB	advmod
2	CD	nummod
mg	NN	pobj
to	IN	prep
about	RB	advmod
4	CD	nummod
mg	NN	pobj
of	IN	prep
micronized	JJ	amod
drospirenone	NN	compound
particle	NNS	pobj
,	,	punct
about	RB	advmod
0.01	CD	nummod
mg	NN	pobj
to	IN	prep
about	RB	advmod
0.05	CD	nummod
mg	NNS	pobj
of	IN	prep
17.alpha.-ethinylestradiol	CD	pobj
,	,	punct
and	CC	cc
one	CD	nummod
or	CC	cc
more	RBR	conj
pharmaceutically	RB	advmod
acceptable	JJ	amod
carrier	NNS	conj
,	,	punct

 	_SP	
the	DT	det
composition	NN	nsubj
be	VBG	acl
in	IN	prep
an	DT	det
oral	JJ	amod
dose	NN	compound
form	NN	pobj
expose	VBN	acl
to	IN	prep
the	DT	det
gastric	JJ	amod
environment	NN	pobj
upon	IN	prep
dissolution	NN	pobj
,	,	punct

 	_SP	
and	CC	cc
the	DT	det
composition	NN	nsubj
be	VBG	acl
effective	JJ	acomp
for	IN	prep
oral	JJ	amod
contraception	NN	pobj
in	IN	prep
a	DT	det
human	JJ	amod
female	NN	pobj
.	.	punct

 	_SP	

Barr	NNP	compound
Laboratories	NNP	nsubj
(	-LRB-	punct
"	``	punct
Barr	NNP	appos
"	''	punct
)	-RRB-	punct
make	VBZ	ROOT
generic	JJ	amod
pharmaceutical	NNS	dobj
,	,	punct
and	CC	cc
file	VBD	conj
an	DT	det
Abbreviated	NNP	compound
New	NNP	compound
Drug	NNP	compound
Application	NNP	dobj
with	IN	prep
the	DT	det
Food	NNP	nmod
and	CC	cc
Drug	NNP	conj
Administration	NNP	pobj
seek	VBG	advcl
approval	NN	dobj
to	TO	aux
market	VB	acl
a	DT	det
generic	JJ	amod
version	NN	dobj
of	IN	prep
Yasmin	NNP	compound
(r)	SYM	pobj
.	.	punct

Bayer	NNP	nsubj
promptly	RB	advmod
file	VBD	ROOT
a	DT	det
patent	NN	compound
infringement	NN	compound
suit	NN	dobj
against	IN	prep
Barr	NNP	pobj
.	.	punct

the	DT	det
party	NNS	nsubj
agree	VBD	ROOT
that	IN	mark
if	IN	mark
the	DT	det
¡¬531	JJ	nummod
patent	NN	nsubj
be	VBZ	advcl
valid	JJ	acomp
,	,	punct
Barr	NNP	nsubj
infringe	VBZ	ccomp
claim	VBZ	dobj
1	CD	nummod
,	,	punct
5	CD	appos
,	,	punct
8	CD	appos
,	,	punct
27	CD	appos
,	,	punct
29	CD	appos
,	,	punct
36	CD	appos
,	,	punct
49	CD	appos
,	,	punct
and	CC	cc
50	CD	conj
.	.	punct

Barr	NNP	nsubj
then	RB	advmod
allege	VBD	ROOT
that	IN	mark
these	DT	det
claim	NNS	nsubj
be	VBP	ccomp
obvious	JJ	acomp
,	,	punct
among	IN	prep
other	JJ	amod
invalidity	NN	pobj
and	CC	cc
unenforceability	NN	compound
argument	NNS	conj
.	.	punct

At	IN	prep
trial	NN	pobj
,	,	punct
the	DT	det
two	CD	nummod
party	NNS	nsubj
agree	VBD	ROOT
that	IN	mark
2	CD	nummod
-	SYM	punct
4	CD	nummod
mg	NN	compound
drospirenone	NN	nsubj
be	VBD	ccomp
well	RB	advmod
know	VBN	acomp
in	IN	prep
the	DT	det
art	NN	pobj
,	,	punct
as	RB	advmod
well	RB	advmod
as	IN	cc
-PRON-	PRP$	poss
combination	NN	attr
with	IN	prep
0.01	CD	nummod
-	SYM	punct
0.05	CD	nummod
mg	NN	compound
17a	NNS	pobj
-	:	punct
ethinylestradiol	NNS	npadvmod
,	,	punct
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
carrier	NN	appos
,	,	punct
and	CC	cc
a	DT	det
kit	NN	conj
contain	VBG	acl
21	CD	nummod
such	JJ	amod
tablet	NNS	dobj
with	IN	prep
active	JJ	amod
ingredient	NNS	pobj
and	CC	cc
7	CD	nummod
placebo	NNS	conj
,	,	punct
to	TO	aux
be	VB	auxpass
use	VBN	relcl
as	IN	prep
an	DT	det
effective	JJ	amod
oral	JJ	amod
contraceptive	NN	pobj
in	IN	prep
human	JJ	amod
female	NNS	pobj
.	.	punct

Bayer	NNP	nsubj
claim	VBD	ROOT
that	IN	mark
-PRON-	PRP$	poss
innovation	NN	nsubj
be	VBD	ccomp
that	IN	mark
the	DT	det
drospirenone	NN	nsubjpass
could	MD	aux
be	VB	auxpass
micronize	VBN	ccomp
to	TO	aux
increase	VB	advcl
-PRON-	PRP$	poss
bioavailability	NN	dobj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
micronized	JJ	amod
drospirenone	NN	nsubj
would	MD	aux
not	RB	neg
need	VB	conj
to	TO	aux
be	VB	xcomp
enteric	JJ	acomp
coated	JJ	acomp
for	IN	prep
protection	NN	pobj
against	IN	prep
the	DT	det
highly	RB	advmod
acidic	JJ	amod
gastric	JJ	amod
environment	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
rule	VBD	ROOT
that	IN	mark
these	DT	det
claim	NNS	nsubj
be	VBD	ccomp
invalid	JJ	acomp
as	IN	prep
obvious	JJ	amod
,	,	punct
and	CC	cc
reject	VBD	conj
Barr	NNP	poss
's	POS	case
other	JJ	amod
theory	NNS	dobj
.	.	punct

the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
consider	VBN	ccomp
the	DT	det
Krause	NNP	dobj
I	NNP	nmod
,	,	punct
II	NNP	conj
,	,	punct
and	CC	cc
III	NNP	compound
study	NNS	poss
'	POS	case
result	NNS	oprd
that	WDT	nsubj
spirorenone	VBD	relcl
though	IN	mark
acid	NN	compound
-	HYPH	punct
sensitive	JJ	nsubj
would	MD	aux
nevertheless	RB	advmod
absorb	VB	advcl
in	IN	prep
vivo	NNS	pobj
because	IN	mark
drospirenone	NN	nsubj
be	VBZ	advcl
closely	RB	advmod
related	JJ	acomp
to	IN	prep
spirorenone	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
also	RB	advmod
find	VBD	ROOT
that	IN	mark
while	IN	mark
the	DT	det
Nickisch	NNP	compound
reference	NN	nsubj
do	VBD	aux
teach	VB	advcl
that	IN	det
drospirenone	NN	ccomp
isomerize	NNS	dobj
in	IN	prep
vitro	NN	pobj
when	WRB	advmod
expose	VBN	advcl
to	IN	prep
acid	NN	pobj
simulate	VBG	xcomp
the	DT	det
human	JJ	amod
stomach	NN	dobj
,	,	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
be	VB	ccomp
aware	JJ	acomp
of	IN	prep
the	DT	det
study	NN	poss
's	POS	case
shortcoming	NNS	pobj
,	,	punct
and	CC	cc
would	MD	aux
verify	VB	conj
whether	IN	mark
drospirenone	NN	nsubj
absorb	VBN	ccomp
or	CC	cc
isomerize	VBN	conj
with	IN	prep
precise	JJ	pobj
in	IN	prep
vivo	NNS	pobj
and	CC	cc
in	IN	conj
vitro	NN	compound
testing	NN	pobj
as	IN	mark
suggest	VBN	advcl
by	IN	agent
the	DT	det
Robert	NNP	compound
Aulton	NNP	compound
treatise	NN	pobj
,	,	punct
Pharmaceutrics	NNPS	npadvmod
:	:	punct

the	DT	det
Science	NNP	ROOT
of	IN	prep
Dosage	NNP	compound
Form	NNP	compound
Design	NNP	pobj
(	-LRB-	punct
1988	CD	appos
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
then	RB	advmod
hold	VBD	ROOT
that	IN	dobj
under	IN	prep
KSR	NNP	compound
International	NNP	compound
Co.	NNP	pobj
v.	CC	prep
Teleflex	NNP	compound
Inc.	NNP	pobj
,	,	punct
550	CD	nummod
U.S.	NNP	appos
398	CD	nummod
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct

1727	CD	npadvmod
,	,	punct
167	CD	nummod
l.ed.2d	NN	appos
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
,	,	punct
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ROOT
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
pharmaceutical	NN	amod
formulation	NN	pobj
to	TO	aux
try	VB	advcl
a	DT	det
normal	JJ	amod
pill	NN	dobj
in	IN	prep
formulate	VBG	pcomp
drospirenone	NN	dobj
as	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
.	.	punct

bayer	NN	nsubj
timely	RB	advmod
appeal	NNS	ccomp
this	DT	det
ruling	NN	dobj
;	:	punct
Barr	NNP	nsubj
do	VBZ	aux
not	RB	neg
cross	VB	subtok
-	JJ	subtok
appeal	VB	ROOT
-PRON-	PRP$	poss
adverse	JJ	amod
ruling	NNS	dobj
.	.	punct

-PRON-	PRP	nsubj
have	VBP	ROOT
jurisdiction	NN	dobj
pursuant	JJ	advmod
to	IN	prep
28	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	nummod
1295(a)(1	CD	pobj
)	-RRB-	punct
.	.	punct

  	_SP	

obviousness	JJ	nsubj
under	IN	quantmod
35	CD	appos
U.S.C.	NNP	npadvmod
¡±	CD	nummod
103	CD	nummod
be	VBZ	ROOT
the	DT	det
sole	JJ	amod
issue	NN	attr
in	IN	prep
this	DT	det
appeal	NN	pobj
.	.	punct

Whether	IN	mark
an	DT	det
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	csubj
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
be	VBZ	ROOT
a	DT	det
question	NN	attr
of	IN	prep
law	NN	pobj
,	,	punct
which	WDT	pobj
-PRON-	PRP	nsubj
review	VBP	relcl
de	FW	compound
novo	NN	dobj
,	,	punct
base	VBN	prep
on	IN	prep
underlie	VBG	amod
fact	NNS	pobj
,	,	punct
which	WDT	dobj
-PRON-	PRP	nsubj
review	VBP	advcl
for	IN	prep
clear	JJ	amod
error	NN	pobj
.	.	punct

Takeda	NNP	ROOT
Chem	NNP	dobj
.	.	punct

Indus	NNP	ROOT
.	.	punct
,	,	punct
Ltd.	NNP	conj
v.	CC	prep
Alphapharm	NNP	compound
Pty	NNP	subtok
.	NNP	pobj
,	,	punct
Ltd.	NNP	appos
,	,	punct
492	CD	nummod
f.3d	CD	appos
1350	CD	appos
,	,	punct
1355	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2007	ADD	conj
)	-RRB-	punct
.	.	punct

a	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	nsubj
be	VBZ	ROOT
clearly	RB	advmod
erroneous	JJ	acomp
when	WRB	advmod
,	,	punct
despite	IN	prep
some	DT	det
support	VBG	amod
evidence	NN	pobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBP	auxpass
"	``	punct
leave	VBN	advcl
with	IN	prep
the	DT	det
definite	JJ	amod
and	CC	cc
firm	JJ	conj
conviction	NN	pobj
that	IN	mark
a	DT	det
mistake	NN	nsubjpass
have	VBZ	aux
be	VBN	auxpass
commit	VBN	acl
"	''	punct
.	.	punct

Forest	NNP	compound
Labs.	NNP	ROOT
,	,	punct
Inc.	NNP	npadvmod
v.	IN	prep
Abbott	NNP	compound
Labs.	NNP	pobj
,	,	punct
339	CD	nummod
f.3d	CD	appos
1324	CD	npadvmod
,	,	punct
1328	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2003	NFP	appos
)	-RRB-	punct
(	-LRB-	punct
quote	VBG	acl
United	NNP	compound
States	NNP	dobj
v.	IN	prep
U.S.	NNP	compound
Gypsum	NNP	compound
Co.	NNP	pobj
,	,	punct
333	CD	nummod
U.S.	NNP	appos
364	CD	nummod
,	,	punct
395	CD	appos
,	,	punct
68	CD	nummod
s.ct	NN	subtok
.	.	punct
525	CD	nummod
,	,	punct
92	CD	nummod
L.Ed	NNS	subtok
.	.	punct
746	CD	appos
(	-LRB-	punct
1948	CD	appos
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

  	_SP	

a	DT	det
patent	NN	nsubjpass
may	MD	aux
not	RB	neg
be	VB	auxpass
obtain	VBN	ROOT
if	IN	mark
the	DT	det
difference	NNS	nsubj
between	IN	prep
the	DT	det
subject	JJ	amod
matter	NN	pobj
seek	VBD	advcl
to	TO	aux
be	VB	auxpass
patent	VBN	xcomp
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBP	conj
such	JJ	acomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
as	IN	prep
a	DT	det
whole	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	prep
which	WDT	pobj
the	DT	det
subject	JJ	amod
matter	NN	nsubj
pertain	VBZ	relcl
.	.	punct

35	CD	nummod
u.s.c.	NN	subtok
¡±	NNP	punct
103(a	CD	ROOT
)	-RRB-	punct
.	.	punct

an	DT	det
obviousness	JJ	amod
analysis	NN	nsubjpass
be	VBZ	auxpass
base	VBN	ROOT
on	IN	prep
several	JJ	amod
factual	JJ	amod
inquiry	NNS	pobj
.	.	punct

a	DT	det
court	NN	nsubj
must	MD	aux
examine	VB	ROOT
the	DT	det
scope	NN	dobj
and	CC	cc
content	NN	conj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
the	DT	det
difference	NNS	appos
between	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
the	DT	det
claim	NNS	conj
at	IN	prep
issue	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
level	NN	conj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
pertinent	JJ	amod
art	NN	pobj
.	.	punct

Graham	NNP	ROOT
v.	IN	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	pobj
,	,	punct
383	CD	nummod
U.S.	NNP	conj
1	CD	nummod
,	,	punct
17	CD	npadvmod
-	SYM	punct
18	CD	prep
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct

684	CD	ROOT
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	appos
)	-RRB-	punct
.	.	punct

At	IN	prep
that	DT	det
point	NN	pobj
,	,	punct
a	DT	det
court	NN	nsubj
may	MD	aux
consider	VB	ROOT
secondary	JJ	amod
objective	JJ	amod
evidence	NN	dobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
,	,	punct
such	JJ	amod
as	IN	prep
commercial	JJ	amod
success	NN	pobj
,	,	punct
long	RB	advmod
feel	VBD	conj
but	CC	cc
unsolved	JJ	amod
need	NN	conj
,	,	punct
failure	NN	appos
of	IN	prep
other	NNS	pobj
,	,	punct
and	CC	cc
the	DT	det
like	JJ	conj
.	.	punct

Idaho	NNP	ROOT

 	_SP	

In	IN	prep
KSR	NNP	pobj
,	,	punct
the	DT	det
Supreme	NNP	compound
Court	NNP	nsubj
state	VBD	ROOT
that	IN	mark
an	DT	det
invention	NN	nsubjpass
may	MD	aux
be	VB	auxpass
find	VBN	ccomp
obvious	JJ	oprd
if	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	advcl
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
to	TO	aux
try	VB	xcomp
a	DT	det
course	NN	dobj
of	IN	prep
conduct	NN	pobj
:	:	punct

 	_SP	

when	WRB	advmod
there	EX	expl
be	VBZ	advcl
a	DT	det
design	NN	compound
need	NN	attr
or	CC	cc
market	NN	compound
pressure	NN	conj
to	TO	aux
solve	VB	acl
a	DT	det
problem	NN	dobj
and	CC	cc
there	EX	expl
be	VBP	conj
a	DT	det
finite	JJ	amod
number	NN	attr
of	IN	prep
identify	VBN	amod
,	,	punct
predictable	JJ	amod
solution	NNS	pobj
,	,	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
have	VBZ	ROOT
good	JJ	amod
reason	NN	dobj
to	TO	aux
pursue	VB	relcl
the	DT	det
know	VBN	amod
option	NNS	dobj
within	IN	prep
-PRON-	PRP$	poss
or	CC	cc
-PRON-	PRP$	poss
technical	JJ	amod
grasp	NN	pobj
.	.	punct

If	IN	mark
this	DT	nsubj
lead	VBZ	advcl
to	IN	prep
the	DT	det
anticipate	VBN	amod
success	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
likely	RB	acomp
the	DT	det
product	NN	attr
not	RB	neg
of	IN	prep
innovation	NN	pobj
but	CC	cc
of	IN	conj
ordinary	JJ	amod
skill	NN	pobj
and	CC	cc
common	JJ	amod
sense	NN	conj
.	.	punct

In	IN	prep
that	DT	det
instance	NN	pobj
the	DT	det
fact	NN	nsubj
that	IN	mark
a	DT	det
combination	NN	nsubj
be	VBD	acl
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
may	MD	aux
show	VB	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
obvious	JJ	acomp
under	IN	prep
¡±	NNP	pobj
103	CD	nummod
.	.	punct

 	_SP	

550	CD	nummod
U.S.	NNP	ROOT
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	appos
.	.	punct

This	DT	det
approach	NN	nsubj
be	VBZ	ROOT
consistent	JJ	acomp
with	IN	prep
-PRON-	PRP$	poss
methodology	NN	pobj
in	IN	prep
In	IN	pobj
re	NN	compound
O'Farrell	NNP	pobj
,	,	punct
853	CD	nummod
f.2d	CD	nummod
894	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1988	CD	appos
)	-RRB-	punct
.	.	punct

see	VB	ROOT
Proctor	NNP	dobj
&	CC	cc
Gamble	NNP	compound
Co.	NNP	conj
v.	CC	prep
Teva	NNP	compound
Pharms	NNP	pobj
.	.	punct

USA	NNP	nmod
,	,	punct
Inc.	NNP	ROOT
,	,	punct
566	CD	nummod
F.3d	NNP	appos
989	CD	nummod
,	,	punct
996	CD	nummod
-	SYM	punct
97	CD	prep
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2009	LS	appos
)	-RRB-	punct
;	.	punct

In	IN	ROOT
re	IN	pobj
Kubin	NNP	pobj
,	,	punct
561	CD	nummod
f.3d	CD	pobj
1351	CD	nummod
,	,	punct
1359	CD	appos
,	,	punct
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2009	LS	appos
)	-RRB-	punct
.	.	punct

O'Farrell	NNP	nsubj
observe	VBD	ROOT
that	IN	mark
most	JJS	amod
invention	NNS	nsubj
that	WDT	nsubj
be	VBP	relcl
obvious	JJ	acomp
be	VBD	ccomp
also	RB	advmod
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
,	,	punct
but	CC	cc
find	VBD	conj
two	CD	nummod
class	NNS	dobj
where	WRB	advmod
that	DT	det
rule	NN	nsubj
of	IN	prep
thumb	NN	pobj
do	VBD	aux
not	RB	neg
obtain	VB	relcl
.	.	punct

  	_SP	

first	RB	advmod
,	,	punct
an	DT	det
invention	NN	nsubj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	ROOT
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
when	WRB	advmod
the	DT	det
inventor	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	ccomp
to	TO	aux
try	VB	xcomp
all	DT	det
possibility	NNS	dobj
in	IN	prep
a	DT	det
field	NN	pobj
unreduce	VBN	acl
by	IN	agent
direction	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

when	WRB	advmod
"	``	punct
what	WP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ROOT
'	``	punct
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
'	''	punct
would	MD	aux
have	VB	aux
be	VBN	ccomp
to	TO	aux
vary	VB	xcomp
all	DT	det
parameter	NNS	dobj
or	CC	cc
try	VB	conj
each	DT	dobj
of	IN	prep
numerous	JJ	amod
possible	JJ	amod
choice	NNS	pobj
until	IN	mark
one	CD	pobj
possibly	RB	advmod
arrive	VBD	acl
at	IN	prep
a	DT	det
successful	JJ	amod
result	NN	pobj
,	,	punct
where	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
give	VBD	relcl
either	CC	preconj
no	DT	det
indication	NN	dobj
of	IN	prep
which	WDT	pobj
parameter	NNS	nsubj
be	VBD	relcl
critical	JJ	acomp
or	CC	cc
no	DT	det
direction	NN	conj
as	IN	mark
to	IN	prep
which	WDT	pobj
of	IN	prep
many	JJ	amod
possible	JJ	amod
choice	NNS	pobj
be	VBZ	advcl
likely	JJ	acomp
to	TO	aux
be	VB	xcomp
successful	JJ	acomp
"	``	punct
an	DT	det
invention	NN	nsubj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	advcl
obvious	JJ	acomp
.	.	punct

O'Farrell	NNP	ROOT
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
another	DT	det
way	NN	attr
to	TO	aux
express	VB	relcl
the	DT	det
KSR	NNP	compound
prong	NN	dobj
require	VBG	acl
the	DT	det
field	NN	dobj
of	IN	prep
search	NN	pobj
to	TO	aux
be	VB	xcomp
among	IN	prep
a	DT	det
"	``	punct
finite	JJ	amod
number	NN	pobj
of	IN	prep
identify	VBN	amod
"	``	punct
solution	NNS	pobj
.	.	punct

550	CD	nummod
U.S.	NNP	nsubj
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	nummod
;	:	punct
see	VB	ROOT
also	RB	advmod
Proctor	NNP	dobj
&	CC	cc
Gamble	NNP	conj
,	,	punct
566	CD	nummod
f.3d	CD	appos
at	IN	prep
996	CD	pobj
;	:	punct

Kubin	NNP	ROOT
,	,	punct
561	CD	nummod
f.3d	CD	appos
at	IN	prep
1359	CD	pobj
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
also	RB	advmod
consistent	JJ	acomp
with	IN	prep
-PRON-	PRP$	poss
interpretation	NN	pobj
that	IN	mark
KSR	NNP	nsubj
require	VBZ	acl
the	DT	det
number	NN	dobj
of	IN	prep
option	NNS	pobj
to	TO	aux
be	VB	advcl
"	``	punct
small	JJ	acomp
or	CC	cc
easily	RB	advmod
traverse	VBN	conj
"	''	punct
.	.	punct

Ortho	NNP	compound
-	HYPH	punct
McNeil	NNP	compound
Pharm.	NNP	nmod
,	,	punct
Inc.	NNP	npadvmod
v.	CC	prep
Mylan	NNP	compound
Labs.	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
520	CD	nummod
F.3d	NNP	appos
1358	CD	nummod
,	,	punct
1364	CD	npadvmod
(	-LRB-	punct
Fed	NNP	ROOT
.	.	punct
Cir.2008	LS	npadvmod
)	-RRB-	punct
.	.	punct

  	_SP	

second	JJ	npadvmod
,	,	punct
an	DT	det
invention	NN	nsubj
be	VBZ	ROOT
not	RB	neg
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
where	WRB	advmod
vague	JJ	amod
prior	JJ	amod
art	NN	nsubj
do	VBZ	aux
not	RB	neg
guide	VB	ccomp
an	DT	det
inventor	NN	dobj
toward	IN	prep
a	DT	det
particular	JJ	amod
solution	NN	pobj
.	.	punct

a	DT	det
finding	NN	nsubj
of	IN	prep
obviousness	NN	pobj
would	MD	aux
not	RB	neg
obtain	VB	ROOT
where	WRB	advmod
"	``	punct
what	WP	nsubj
be	VBD	csubj
'	``	punct
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
'	''	punct
be	VBD	ccomp
to	TO	aux
explore	VB	xcomp
a	DT	det
new	JJ	amod
technology	NN	dobj
or	CC	cc
general	JJ	amod
approach	NN	conj
that	WDT	nsubj
seem	VBD	relcl
to	TO	aux
be	VB	xcomp
a	DT	det
promising	JJ	amod
field	NN	attr
of	IN	prep
experimentation	NN	pobj
,	,	punct
where	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
give	VBD	relcl
only	RB	advmod
general	JJ	amod
guidance	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
particular	JJ	amod
form	NN	pobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
or	CC	cc
how	WRB	advmod
to	TO	aux
achieve	VB	conj
-PRON-	PRP	dobj
"	''	punct
.	.	punct

O'Farrell	NNP	ROOT
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
.	.	punct

This	DT	nsubj
express	VBZ	ROOT
the	DT	det
same	JJ	amod
idea	NN	dobj
as	IN	mark
the	DT	det
KSR	NNP	compound
requirement	NN	advcl
that	IN	mark
the	DT	det
identify	VBN	amod
solution	NNS	nsubj
be	VB	ccomp
"	``	punct
predictable	JJ	acomp
"	''	punct
.	.	punct

550	CD	nummod
U.S.	NNP	nsubj
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	nummod
;	:	punct
see	VB	ROOT
also	RB	advmod
Proctor	NNP	dobj
&	CC	cc
Gamble	NNP	conj
,	,	punct
566	CD	nummod
f.3d	CD	appos
at	IN	prep
996	CD	pobj
-	SYM	punct
97	CD	prep
;	:	punct
Kubin	NNP	appos
,	,	punct
561	CD	nummod
f.3d	CD	appos
at	IN	prep
1359	CD	pobj
-	SYM	punct
60	CD	prep
.	.	punct

  	_SP	

Because	IN	mark
the	DT	det
use	NN	nsubjpass
of	IN	prep
drospirenone	NN	pobj
with	IN	prep
17a	NNS	compound
-	:	punct
ethinylestradiol	NNS	pobj
as	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
be	VBD	auxpass
know	VBN	advcl
prior	JJ	amod
art	NN	oprd
,	,	punct
Bayer	NNP	nsubj
represent	VBD	ROOT
that	IN	mark
the	DT	det
innovation	NN	nsubj
be	VBD	ccomp
to	TO	aux
micronize	VB	xcomp
the	DT	det
drospirenone	NN	dobj
to	TO	aux
increase	VB	relcl
-PRON-	PRP$	poss
bioavailability	NN	dobj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
micronized	JJ	amod
drospirenone	NN	nsubj
would	MD	aux
absorb	VB	conj
with	IN	prep
a	DT	det
normal	JJ	amod
pill	NN	pobj
,	,	punct
against	IN	prep
the	DT	det
teaching	NNS	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
analyze	VBD	ROOT
the	DT	det
prior	JJ	amod
art	NN	dobj
and	CC	cc
determine	VBD	conj
that	IN	mark
micronize	VBG	compound
drospirenone	NN	nsubjpass
be	VBD	auxpass
teach	VBN	ccomp
,	,	punct
and	CC	cc
that	IN	mark
use	VBG	csubj
a	DT	det
normal	JJ	amod
pill	NN	dobj
would	MD	aux
have	VB	aux
be	VBN	conj
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
.	.	punct

 	_SP	

the	DT	det
court	NN	nsubj
first	RB	advmod
determine	VBD	ROOT
how	WRB	advmod
the	DT	det
person	NN	nsubj
have	VBG	csubj
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
of	IN	prep
pharmaceutical	NN	amod
formulation	NN	pobj
would	MD	aux
consider	VB	ccomp
the	DT	det
correlation	NN	dobj
of	IN	prep
in	IN	prep
vitro	FW	pobj
and	CC	cc
in	IN	conj
vivo	NNS	compound
test	NNS	pobj
.	.	punct

-PRON-	PRP	nsubj
rely	VBD	ROOT
principally	RB	advmod
on	IN	prep
Robert	NNP	compound
Aulton	NNP	poss
's	POS	case
pharmacologist	NN	compound
textbook	NN	pobj
,	,	punct
pharmaceutic	NNS	appos
:	:	punct

the	DT	det
Science	NNP	ROOT
of	IN	prep
Dosage	NNP	compound
Form	NNP	compound
Design	NNP	pobj
,	,	punct
which	WDT	nsubj
,	,	punct
as	IN	mark
the	DT	det
court	NN	nsubj
find	VBD	advcl
,	,	punct
teach	VBZ	relcl
that	IN	mark
"	``	punct
dissolution	NN	compound
rate	NN	compound
datum	NNS	nsubj
when	WRB	advmod
combine	VBN	relcl
with	IN	prep
solubility	NN	pobj
...	:	punct
provide	VB	ccomp
an	DT	det
insight	NN	dobj
to	IN	prep
the	DT	det
formulator	NN	pobj
into	IN	prep
the	DT	det
potential	NN	pobj
in	IN	prep
vivo	NNS	compound
absorption	NN	compound
characteristic	NNS	pobj
of	IN	prep
a	DT	det
drug	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
in	IN	prep
vitro	FW	compound
test	NNS	pobj
only	RB	advmod
have	VBP	ROOT
significance	NN	dobj
if	IN	mark
-PRON-	PRP	nsubjpass
can	MD	aux
be	VB	auxpass
relate	VBN	advcl
to	IN	prep
in	IN	prep
vivo	NNS	compound
result	NNS	pobj
.	.	punct

once	RB	mark
such	PDT	predet
a	DT	det
relationship	NN	nsubjpass
have	VBZ	aux
be	VBN	auxpass
establish	VBN	advcl
,	,	punct
in	IN	prep
vitro	FW	pobj
dissolution	NN	compound
test	NNS	nsubjpass
can	MD	aux
be	VB	auxpass
use	VBN	ROOT
as	IN	prep
a	DT	det
quality	NN	compound
control	NN	compound
test	NN	pobj
.	.	punct
(	-LRB-	punct
Aulton	NNP	npadvmod
,	,	punct
p.	NN	appos
9	CD	nummod
)	-RRB-	punct
.	.	punct
"	''	punct

the	DT	det
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
the	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
not	RB	neg
accept	VB	ccomp
in	IN	prep
vitro	NN	compound
testing	NN	pobj
as	IN	prep
valid	JJ	amod
without	IN	prep
a	DT	det
correlation	NN	pobj
to	IN	aux
in	IN	advcl
vivo	NNS	compound
test	NNS	pobj
.	.	punct

 	_SP	

With	IN	prep
that	DT	det
knowledge	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
then	RB	advmod
turn	VBD	ROOT
to	IN	prep
micronization	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
find	VBD	ROOT
that	IN	mark
Aulton	NNP	nsubj
cut	VBD	ccomp
both	DT	det
way	NNS	dobj
on	IN	prep
this	DT	det
point	NN	pobj
,	,	punct
because	IN	mark
-PRON-	PRP	nsubj
teach	VBD	advcl
both	DT	preconj
that	IN	mark
micronize	VBG	csubj
a	DT	det
poorly	JJ	advmod
water	NN	nmod
soluble	JJ	amod
substance	NN	dobj
like	IN	prep
drospirenone	NN	pobj
may	MD	aux
increase	VB	ccomp
-PRON-	PRP$	poss
absorption	NN	compound
rate	NN	dobj
,	,	punct
but	CC	cc
may	MD	aux
also	RB	advmod
increase	VB	conj
the	DT	det
rate	NN	dobj
of	IN	prep
degradation	NN	pobj
.	.	punct

however	RB	advmod
,	,	punct
Aulton	NNP	nsubj
state	VBD	ROOT
,	,	punct
and	CC	cc
other	JJ	amod
evidence	NN	nsubj
corroborate	VBD	conj
,	,	punct
that	IN	mark
"	``	punct
-PRON-	PRP	nsubjpass
be	VBZ	auxpass
now	RB	advmod
generally	RB	advmod
recognize	VBN	ccomp
that	IN	mark
poorly	RB	advmod
soluble	JJ	amod
drug	NNS	nsubj
show	VBG	acl
a	DT	det
dissolution	NN	compound
rate	NN	npadvmod
limit	VBG	compound
step	NN	dobj
in	IN	prep
the	DT	det
absorption	NN	compound
process	NN	pobj
will	MD	aux
be	VB	ccomp
more	RBR	advmod
readily	RB	advmod
bioavailable	JJ	acomp
when	WRB	advmod
administer	VBN	advcl
in	IN	prep
a	DT	det
finely	RB	advmod
subdivide	VBN	amod
[	-LRB-	punct
micronized	JJ	amod
]	-RRB-	punct
form	NN	pobj
with	IN	prep
large	JJR	amod
surface	NNS	pobj
than	IN	prep
as	IN	prep
the	DT	det
coarse	JJ	amod
material	NN	pobj
....	.	punct

the	DT	det
fine	JJ	amod
material	NN	ROOT
often	RB	advmod
in	IN	prep
micronized	JJ	amod
form	NN	pobj
with	IN	prep
large	JJR	amod
specific	JJ	amod
surface	NN	compound
dissolve	NNS	pobj
at	IN	prep
fast	JJR	amod
rate	NNS	pobj
which	WDT	nsubj
can	MD	aux
lead	VB	relcl
to	IN	prep
improve	VBN	amod
drug	NN	compound
absorption	NN	pobj
by	IN	prep
passive	JJ	amod
diffusion	NN	pobj
"	''	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
acknowledge	VBD	ROOT
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
suggest	VBD	ccomp
that	IN	mark
there	EX	expl
would	MD	aux
be	VB	ccomp
concern	NN	attr
about	IN	prep
the	DT	det
dissolution	NN	pobj
of	IN	prep
a	DT	det
poorly	JJ	advmod
water	NN	nmod
soluble	JJ	amod
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NN	pobj
,	,	punct
but	CC	cc
find	VBD	conj
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
generally	RB	advmod
suggest	VBZ	ccomp
that	IN	mark
micronization	NN	nsubj
could	MD	aux
improve	VB	ccomp
the	DT	det
dissolution	NN	dobj
of	IN	prep
drospirenone	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
conclude	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
would	MD	aux
have	VB	aux
see	VBN	ccomp
-PRON-	PRP	dobj
as	IN	prep
a	DT	det
viable	JJ	amod
option	NN	pobj
.	.	punct

 	_SP	

Bayer	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
this	DT	nsubj
be	VBZ	ccomp
clear	JJ	amod
error	NN	attr
because	IN	mark
the	DT	det
court	NN	nsubj
rely	VBD	advcl
on	IN	prep
one	CD	nummod
piece	NN	pobj
of	IN	prep
prior	JJ	amod
art	NN	pobj
to	TO	aux
show	VB	advcl
that	IN	mark
micronization	NN	nsubjpass
have	VBZ	aux
be	VBN	auxpass
show	VBN	ccomp
to	TO	aux
work	VB	xcomp
on	IN	prep
acid	NN	compound
-	HYPH	punct
sensitive	JJ	amod
compound	NNS	pobj
.	.	punct

the	DT	det
court	NN	nsubj
review	VBD	ROOT
the	DT	det
Hargrove	NNP	compound
reference	NN	dobj
,	,	punct
which	WDT	nsubj
be	VBD	relcl
a	DT	det
study	NN	attr
on	IN	prep
micronize	VBG	pcomp
progesterone	NN	dobj
,	,	punct
conclude	VBG	advcl
that	IN	mark
"	``	punct
-PRON-	PRP	nsubj
confirm	VBZ	ccomp
that	IN	mark
not	RB	neg
all	DT	det
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NNS	nsubj
require	VBP	ccomp
enteric	JJ	amod
coating	NN	dobj
"	''	punct
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
incorrect	JJ	acomp
,	,	punct
as	IN	mark
Barr	NNP	nsubj
agree	VBZ	advcl
,	,	punct
because	IN	mark
progesterone	NN	nsubj
be	VBZ	advcl
not	RB	neg
an	DT	det
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NN	attr
.	.	punct

however	RB	advmod
,	,	punct
Bayer	NNP	poss
's	POS	case
own	JJ	amod
expert	NN	nsubj
,	,	punct
Dr.	NNP	compound
James	NNP	compound
McGinity	NNP	appos
,	,	punct
testify	VBD	ROOT
that	IN	mark
micronization	NN	nsubj
be	VBZ	ccomp
the	DT	det
first	JJ	amod
choice	NN	compound
solution	NN	attr
because	IN	mark
-PRON-	PRP	nsubj
present	VBZ	advcl
the	DT	det
good	JJS	amod
chance	NN	dobj
for	IN	prep
success	NN	pobj
.	.	punct

so	RB	advmod
there	EX	expl
remain	VBZ	ROOT
adequate	JJ	amod
support	NN	attr
for	IN	prep
the	DT	det
conclusion	NN	pobj
that	IN	mark
micronization	NN	nsubj
be	VBD	acl
a	DT	det
viable	JJ	amod
option	NN	attr
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
then	RB	advmod
move	VBD	ROOT
to	IN	prep
Bayer	NNP	poss
's	POS	case
second	JJ	amod
allege	VBN	amod
non	JJ	subtok
-	JJ	subtok
obvious	JJ	amod
aspect	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
,	,	punct
whether	IN	mark
the	DT	det
formulation	NN	nsubj
should	MD	aux
use	VB	advcl
an	DT	det
enteric	JJ	advmod
-	HYPH	punct
coated	JJ	amod
or	CC	cc
normal	JJ	conj
tablet	NN	compound
delivery	NN	dobj
.	.	punct

the	DT	det
court	NN	nsubj
consider	VBD	ROOT
Bayer	NNP	poss
's	POS	case
argument	NN	oprd
that	IN	mark
prior	JJ	amod
art	NN	nsubj
teach	VBD	acl
formulation	NN	compound
scientist	NNS	dobj
to	TO	aux
employ	VB	xcomp
an	DT	det
enteric	JJ	amod
coating	NN	dobj
on	IN	prep
drospirenone	NN	pobj
,	,	punct
and	CC	cc
Barr	NNP	poss
's	POS	case
argument	NN	conj
that	IN	mark
an	DT	det
enteric	JJ	amod
coating	NN	nsubj
be	VBZ	acl
so	RB	advmod
complicated	JJ	amod
,	,	punct
expensive	JJ	conj
,	,	punct
cumbersome	VBP	acomp
to	TO	aux
manufacture	VB	xcomp
,	,	punct
and	CC	cc
prone	JJ	conj
to	IN	prep
variability	NN	pobj
that	IN	mark
-PRON-	PRP	nsubjpass
only	RB	advmod
would	MD	aux
be	VB	auxpass
use	VBN	ccomp
as	IN	prep
a	DT	det
last	JJ	amod
resort	NN	pobj
by	IN	agent
formulation	NN	compound
scientist	NNS	pobj
work	VBG	acl
with	IN	prep
an	DT	det
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NN	pobj
.	.	punct

the	DT	det
court	NN	nsubj
find	VBD	ROOT
neither	CC	det
side	NN	compound
persuasive	JJ	dobj
,	,	punct
and	CC	cc
consider	VBD	conj
the	DT	det
prior	JJ	amod
art	NN	dobj
as	IN	prep
the	DT	det
center	NN	pobj
,	,	punct
again	RB	advmod
focus	VBG	advcl
on	IN	prep
the	DT	det
Aulton	NNP	compound
textbook	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
find	VBD	ROOT
that	IN	mark
Aulton	NNP	nsubj
recognize	VBZ	ccomp
the	DT	det
necessity	NN	dobj
of	IN	prep
an	DT	det
enteric	JJ	amod
coating	NN	pobj
to	IN	prep
the	DT	det
formulation	NN	pobj
of	IN	prep
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NNS	pobj
,	,	punct
but	CC	cc
that	IN	mark
an	DT	det
enteric	JJ	amod
coating	NN	nsubj
also	RB	advmod
introduce	VBZ	conj
drawback	NNS	dobj
,	,	punct
include	VBG	prep
that	IN	det
enteric	JJ	amod
coated	JJ	amod
tablet	NNS	pobj
have	VBP	ccomp
the	DT	det
low	JJS	amod
bioavailability	NN	dobj
of	IN	prep
all	DT	det
drug	NN	compound
delivery	NN	compound
form	NNS	pobj
.	.	punct

poor	JJ	amod
bioavailability	NN	nsubj
of	IN	prep
drospirenone	NN	pobj
be	VBZ	ROOT
the	DT	det
major	JJ	amod
problem	NN	attr
that	WDT	dobj
Tack	NNP	nsubj
seek	VBD	relcl
to	TO	aux
solve	VB	xcomp
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
further	RB	advmod
find	VBD	ROOT
that	IN	mark
Aulton	NNP	nsubj
teach	VBZ	ccomp
that	IN	mark
there	EX	expl
be	VBZ	ccomp
variability	NN	attr
in	IN	prep
bioavailability	NN	pobj
both	CC	preconj
intra-	JJ	punct
and	CC	cc
inter	JJ	subtok
-	JJ	subtok
subject	JJ	conj
when	WRB	advmod
use	VBG	advcl
enteric	JJ	amod
coated	JJ	amod
tablet	NNS	dobj
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
a	DT	det
significant	JJ	amod
obstacle	NN	attr
to	IN	prep
Bayer	NNP	poss
's	POS	case
requirement	NN	pobj
that	IN	mark
the	DT	det
drug	NN	nsubj
must	MD	aux
be	VB	acl
99	CD	nummod
%	NN	npadvmod
effective	JJ	acomp
for	IN	prep
all	DT	det
woman	NNS	pobj
.	.	punct

 	_SP	

In	IN	prep
effect	NN	pobj
,	,	punct
while	IN	mark
Bayer	NNP	nsubj
argue	VBD	advcl
that	IN	mark
prior	JJ	amod
art	NN	nsubj
teach	VBZ	ccomp
away	RB	advmod
from	IN	prep
use	VBG	pcomp
micronized	JJ	amod
drospirenone	NN	dobj
in	IN	prep
a	DT	det
normal	JJ	amod
tablet	NN	pobj
,	,	punct
Barr	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
teach	VBZ	ccomp
away	RB	advmod
from	IN	prep
use	VBG	pcomp
an	DT	det
enteric	JJ	amod
coating	NN	dobj
.	.	punct

what	WP	dobj
the	DT	det
party	NNS	nsubj
have	VBP	aux
do	VBN	csubj
,	,	punct
however	RB	advmod
,	,	punct
be	VBZ	ROOT
present	JJ	acomp
the	DT	det
option	NNS	dobj
available	JJ	amod
to	IN	prep
a	DT	det
pharmaceutical	JJ	compound
formulator	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
to	TO	aux
solve	VB	advcl
the	DT	det
problem	NN	dobj
of	IN	prep
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
but	CC	cc
hydrophobic	JJ	conj
drospirenone	NN	pobj
.	.	punct

 	_SP	

Barr	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
Krause	NNP	compound
series	NN	nsubj
on	IN	prep
spirorenone	NN	pobj
be	VBZ	aux
control	VBG	ccomp
because	IN	prep
of	IN	pcomp
the	DT	det
great	JJ	amod
similarity	NN	pobj
between	IN	prep
spirorenone	NN	pobj
and	CC	cc
drospirenone	NN	conj
.	.	punct

the	DT	det
Krause	NNP	compound
series	NN	nsubj
test	VBD	ROOT
the	DT	det
bioavailability	NN	dobj
of	IN	prep
spirorenone	NN	pobj
in	IN	prep
vivo	NNS	pobj
in	IN	prep
human	NNS	pobj
and	CC	cc
monkey	NNS	conj
to	TO	aux
determine	VB	advcl
whether	IN	mark
there	EX	expl
be	VBD	ccomp
need	VB	acomp
to	TO	aux
develop	VB	xcomp
a	DT	det
"	``	punct
pharmaceutical	JJ	amod
formulation	NN	dobj
resistant	JJ	amod
to	IN	prep
gastric	JJ	amod
juice	NN	pobj
"	''	punct
.	.	punct

the	DT	det
study	NNS	nsubj
each	DT	appos
find	VBD	ROOT
no	DT	det
spirorenone	NN	compound
isomer	NNS	dobj
in	IN	prep
the	DT	det
subject	NNS	poss
'	POS	case
blood	NN	compound
stream	NNS	pobj
,	,	punct
and	CC	cc
conclude	VBD	conj
that	IN	mark
spirorenone	NN	nsubjpass
be	VBZ	auxpass
absorb	VBN	ccomp
before	IN	mark
-PRON-	PRP	nsubj
isomerize	VBZ	advcl
.	.	punct

furthermore	RB	advmod
,	,	punct
an	DT	det
in	IN	advmod
vitro	FW	compound
comparison	NN	nsubj
find	VBD	ROOT
that	IN	nsubj
drospirenone	NN	ccomp
isomerize	VBN	acl
in	IN	prep
pH	NNS	subtok
1	CD	nummod
acid	NN	pobj
with	IN	prep
a	DT	det
profile	NN	pobj
similar	JJ	amod
to	IN	aux
spirorenone	NN	xcomp
.	.	punct

the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
drug	NNS	nsubjpass
be	VBD	auxpass
closely	RB	advmod
related	JJ	acomp
in	IN	prep
that	IN	mark
-PRON-	PRP	nsubj
be	VBP	ccomp
both	DT	dep
(	-LRB-	punct
1	LS	nummod
)	-RRB-	punct
acid	NN	compound
-	HYPH	punct
sensitive	JJ	acomp
at	IN	prep
similar	JJ	amod
rate	NNS	pobj
,	,	punct
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
steroid	NNS	ccomp
have	VBG	xcomp
the	DT	det
same	JJ	amod
pharmacological	JJ	amod
property	NNS	dobj
,	,	punct
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
derivative	NNS	conj
of	IN	prep
the	DT	det
same	JJ	amod
drug	NN	pobj
,	,	punct
(	-LRB-	punct
4	LS	appos
)	-RRB-	punct
of	IN	prep
the	DT	det
same	JJ	amod
chemical	NN	compound
composition	NN	pobj
except	IN	prep
for	IN	prep
one	CD	nummod
bond	NN	pobj
,	,	punct
and	CC	cc
(	-LRB-	punct
5	LS	conj
)	-RRB-	punct
from	IN	prep
the	DT	det
same	JJ	amod
family	NN	pobj
of	IN	prep
substance	NNS	pobj
.	.	punct

the	DT	det
court	NN	nsubj
then	RB	advmod
conclude	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
find	VB	ccomp
the	DT	det
drug	NNS	nsubj
closely	RB	advmod
related	JJ	ccomp
,	,	punct
and	CC	cc
would	MD	aux
therefore	RB	advmod
access	VB	conj
these	DT	det
study	NNS	dobj
when	WRB	advmod
formulate	VBG	advcl
drospirenone	NN	dobj
.	.	punct

-PRON-	PRP	nsubjpass
would	MD	aux
be	VB	auxpass
lead	VBN	ROOT
to	TO	aux
believe	VB	xcomp
that	DT	mark
drospirenone	NN	nsubj
,	,	punct
like	IN	prep
spirorenone	NN	pobj
,	,	punct
may	MD	aux
absorb	VB	ccomp
in	IN	prep
vivo	NNS	pobj
,	,	punct
but	CC	cc
isomerize	VB	conj
in	IN	prep
vitro	FW	pobj
.	.	punct

 	_SP	

Bayer	NNP	nsubj
argue	VBZ	ROOT
now	RB	advmod
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
ignore	VBD	ccomp
key	JJ	amod
difference	NNS	dobj
between	IN	prep
drospirenone	NN	pobj
and	CC	cc
spirorenone	NN	conj
,	,	punct
such	JJ	amod
as	IN	prep
that	IN	mark
the	DT	det
former	JJ	amod
isomerize	NNS	pobj
40	CD	nummod
%	NN	npadvmod
faster	RBR	advmod
than	IN	prep
the	DT	det
latter	JJ	pobj
,	,	punct
and	CC	cc
that	DT	det
drospirenone	NN	nsubj
be	VBZ	conj
more	RBR	advmod
soluble	JJ	acomp
and	CC	cc
thus	RB	advmod
could	MD	aux
dissolve	VB	conj
and	CC	cc
isomerize	VB	conj
in	IN	prep
acid	NN	pobj
faster	RBR	advmod
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
irrelevant	JJ	acomp
because	IN	mark
the	DT	det
Krause	NNP	compound
series	NN	nsubj
prior	JJ	amod
art	NN	appos
be	VBZ	advcl
not	RB	neg
an	DT	det
anticipatory	NN	amod
reference	NN	attr
.	.	punct

-PRON-	PRP	nsubjpass
can	MD	aux
be	VB	auxpass
use	VBN	ROOT
to	TO	aux
show	VB	xcomp
that	IN	mark
a	DT	det
drug	NN	compound
formulator	NN	nsubj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
have	VBD	ccomp
a	DT	det
viable	JJ	amod
know	VBN	amod
option	NN	dobj
to	TO	aux
consider	VB	acl
with	IN	prep
micronized	JJ	amod
,	,	punct
unprotected	JJ	amod
drospirenone	NN	pobj
,	,	punct
and	CC	cc
a	DT	det
reasonable	JJ	amod
expectation	NN	conj
that	IN	nsubj
drospirenone	NN	relcl
would	MD	aux
perform	VB	ccomp
similarly	RB	advmod
(	-LRB-	punct
even	RB	advmod
if	IN	mark
not	RB	advcl
identically	RB	advmod
)	-RRB-	punct
to	IN	prep
the	DT	det
spirorenone	NN	pobj
in	IN	prep
the	DT	det
Krause	NNP	compound
series	NN	pobj
.	.	punct

see	VB	advcl
O'Farrell	NNP	dobj
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
-	SYM	punct
904	CD	prep
(	-LRB-	punct
"	``	punct
Obviousness	NNP	nsubj
do	VBZ	aux
not	RB	neg
require	VB	ccomp
absolute	JJ	amod
predictability	NN	dobj
of	IN	prep
success	NN	pobj
...	:	punct
all	DT	nsubj
that	WDT	nsubjpass
be	VBZ	auxpass
require	VBN	relcl
be	VBZ	ROOT
a	DT	det
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

similarly	RB	advmod
,	,	punct
Bayer	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
Nickisch	NNP	compound
article	NN	nsubj
teach	VBZ	ccomp
that	WDT	nsubj
drospirenone	NN	ccomp
isomerize	NNS	dobj
when	WRB	advmod
expose	VBN	advcl
to	IN	prep
acid	NN	pobj
in	IN	prep
vitro	NN	pobj
,	,	punct
teach	VBG	advcl
away	RB	advmod
from	IN	prep
allow	VBG	pcomp
exposure	NN	dobj
to	IN	prep
the	DT	det
gastric	JJ	amod
environment	NN	pobj
,	,	punct
and	CC	cc
thus	RB	advmod
suggest	VBG	conj
the	DT	det
need	NN	dobj
for	IN	prep
an	DT	det
enteric	JJ	amod
coating	NN	pobj
.	.	punct

Barr	NNP	nsubj
attack	VBD	ROOT
the	DT	det
merit	NNS	dobj
of	IN	prep
the	DT	det
study	NN	pobj
as	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
apply	VB	advcl
to	IN	prep
the	DT	det
practice	NN	pobj
of	IN	prep
drospirenone	NN	pobj
in	IN	prep
vivo	NNS	pobj
,	,	punct
note	VBG	advcl
that	IN	mark
Nickisch	NNP	nsubj
do	VBD	aux
not	RB	neg
test	VB	ccomp
drospirenone	NN	dobj
in	IN	prep
vivo	NNS	pobj
to	TO	aux
correlate	VB	advcl
-PRON-	PRP$	dobj
in	FW	prep
vitro	FW	compound
finding	NNS	pobj
.	.	punct

Barr	NNP	nsubj
also	RB	advmod
challenge	VBD	ROOT
the	DT	det
Nickisch	NNP	compound
reference	NN	dobj
on	IN	prep
the	DT	det
ground	NNS	pobj
that	WDT	nsubj
drospirenone	NN	nsubjpass
be	VBD	auxpass
find	VBN	relcl
to	TO	aux
isomerize	VB	xcomp
slowly	RB	advmod
and	CC	cc
would	MD	aux
not	RB	neg
have	VB	aux
isomerize	VBN	conj
before	IN	mark
the	DT	det
stomach	NN	nsubj
empty	VBD	advcl
,	,	punct
that	IN	mark
the	DT	det
in	IN	nmod
vitro	FW	amod
environment	NN	nsubj
be	VBD	conj
too	RB	advmod
extreme	JJ	acomp
to	TO	aux
be	VB	auxpass
compare	VBN	advcl
to	IN	prep
an	DT	pobj
in	IN	prep
vivo	NNS	compound
practice	NN	pobj
,	,	punct
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
explain	VB	conj
-PRON-	PRP$	poss
testing	NN	compound
proto	NN	compound
col	NNS	dobj
.	.	punct

the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
recognize	VB	ccomp
that	IN	mark
Nickisch	NNP	nsubj
establish	VBZ	ccomp
that	WDT	nsubj
drospirenone	NN	ccomp
isomerize	NNS	dobj
in	IN	prep
vitro	NN	pobj
,	,	punct
but	CC	cc
would	MD	aux
be	VB	auxpass
alert	VBN	conj
to	IN	prep
the	DT	det
study	NN	poss
's	POS	case
shortcoming	NNS	pobj
when	WRB	advmod
use	VBN	advcl
in	IN	prep
vivo	NNS	pobj
.	.	punct

 	_SP	

At	IN	prep
this	DT	det
point	NN	pobj
,	,	punct
a	DT	det
person	NN	nsubj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
have	VBZ	aux
reach	VBN	ROOT
a	DT	det
crossroad	NNS	dobj
where	WRB	advmod
-PRON-	PRP	nsubj
must	MD	aux
choose	VB	relcl
between	IN	prep
two	CD	nummod
know	VBN	amod
option	NNS	pobj
:	:	punct
delivery	NN	appos
of	IN	prep
micronized	JJ	amod
drospirenone	NN	pobj
by	IN	prep
a	DT	det
normal	JJ	amod
pill	NN	pobj
follow	VBG	acl
the	DT	det
spirorenone	NN	compound
analogy	NN	dobj
in	IN	prep
the	DT	det
Krause	NNP	compound
series	NN	pobj
,	,	punct
or	CC	cc
delivery	NN	conj
of	IN	prep
drospirenone	NN	pobj
by	IN	prep
an	DT	det
enteric	JJ	amod
-	HYPH	punct
coated	JJ	amod
pill	NN	pobj
follow	VBG	prep
the	DT	det
Nickisch	NNP	compound
teaching	NN	pobj
that	WDT	mark
the	DT	det
drug	NN	nsubj
need	VBZ	relcl
to	TO	aux
be	VB	auxpass
protect	VBN	xcomp
from	IN	prep
the	DT	det
stomach	NN	pobj
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
a	DT	det
finite	JJ	amod
number	NN	attr
of	IN	prep
identify	VBN	amod
,	,	punct
predictable	JJ	amod
solution	NNS	pobj
.	.	punct

see	VB	ROOT
KSR	NNP	dobj
.	.	punct

550	CD	nummod
U.S.	NNP	ROOT
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	appos
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
would	MD	aux
have	VB	aux
funnel	VBN	ccomp
the	DT	det
formulator	NN	dobj
toward	IN	prep
these	DT	det
two	CD	nummod
option	NNS	pobj
;	:	punct
-PRON-	PRP	nsubjpass
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	auxpass
require	VBN	ROOT
to	TO	aux
try	VB	xcomp
all	DT	det
possibility	NNS	dobj
in	IN	prep
a	DT	det
field	NN	pobj
unreduce	VBN	acl
by	IN	agent
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
thus	RB	advmod
avoid	VBG	advcl
the	DT	det
first	JJ	amod
pitfall	NN	dobj
of	IN	prep
O'Farrell	NNP	pobj
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
.	.	punct

additionally	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBD	ROOT
not	RB	neg
vague	JJ	acomp
in	IN	prep
point	VBG	pcomp
toward	IN	prep
a	DT	det
general	JJ	amod
approach	NN	pobj
or	CC	cc
area	NN	conj
of	IN	prep
exploration	NN	pobj
,	,	punct
but	CC	cc
rather	RB	advmod
guide	VBD	conj
the	DT	det
formulator	NN	dobj
precisely	RB	advmod
to	IN	prep
the	DT	det
use	NN	pobj
of	IN	prep
either	CC	preconj
a	DT	det
normal	JJ	amod
pill	NN	pobj
or	CC	cc
an	DT	det
enteric	JJ	amod
-	HYPH	punct
coated	JJ	amod
pill	NN	conj
,	,	punct
thus	RB	advmod
avoid	VBG	advcl
the	DT	det
second	JJ	amod
pitfall	NN	dobj
of	IN	prep
O'Farrell	NNP	pobj
.	.	punct

Idaho	NNP	ROOT

Because	IN	mark
the	DT	det
selection	NN	nsubj
of	IN	prep
micronized	JJ	amod
drospirenone	NN	pobj
in	IN	prep
a	DT	det
normal	JJ	amod
pill	NN	pobj
lead	VBD	acl
to	IN	prep
the	DT	det
result	NN	pobj
anticipate	VBN	acl
by	IN	agent
the	DT	det
Krause	NNP	compound
series	NN	pobj
,	,	punct
the	DT	det
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ROOT
obvious	JJ	acomp
.	.	punct

see	VB	compound
KSR	NNP	ROOT
,	,	punct
550	CD	nummod
U.S.	NNP	appos
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	appos
.	.	punct

 	_SP	

accordingly	RB	advmod
,	,	punct
the	DT	det
judgment	NN	nsubjpass
of	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
be	VBZ	auxpass
affirm	VBN	ROOT
.	.	punct

 	_SP	

NEWMAN	NNP	ROOT
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
dissent	VBG	acl
.	.	punct

 	_SP	

With	IN	prep
all	DT	det
respect	NN	pobj
to	IN	prep
-PRON-	PRP$	poss
colleague	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
share	VB	ROOT
-PRON-	PRP$	poss
view	NN	dobj
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	acl
obvious	JJ	acomp
to	TO	aux
do	VB	xcomp
that	DT	dobj
which	WDT	nsubj
be	VBD	advcl
indisputably	RB	advmod
unobvious	JJ	acomp
to	IN	prep
the	DT	det
experienced	JJ	amod
formulation	NN	compound
scientist	NNS	pobj
whose	WP$	poss
assignment	NN	nsubj
be	VBD	relcl
to	TO	aux
formulate	VB	xcomp
the	DT	det
know	VBN	amod
product	NN	compound
drospirenone	NN	dobj
.	.	punct

the	DT	det
evidence	NN	nsubj
show	VBD	ROOT
,	,	punct
without	IN	prep
contradiction	NN	pobj
,	,	punct
that	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	ccomp
that	IN	mark
micronized	JJ	amod
drospirenone	NN	nsubj
rapidly	RB	advmod
degrade	VBD	ccomp
at	IN	prep
the	DT	det
acidity	NN	pobj
of	IN	prep
stomach	NN	compound
acid	NN	pobj
.	.	punct

the	DT	det
evidence	NN	nsubj
show	VBD	ROOT
,	,	punct
without	IN	prep
contradiction	NN	pobj
,	,	punct
that	IN	mark
the	DT	det
Bayer	NNP	compound
scientist	NNS	nsubj
work	VBG	acl
in	IN	prep
this	DT	det
field	NN	pobj
believe	VBD	ccomp
that	IN	mark
the	DT	det
product	NN	nsubj
require	VBD	ccomp
an	DT	det
enteric	JJ	amod
coating	NN	dobj
in	IN	prep
order	NN	pobj
to	TO	aux
prevent	VB	acl
degradation	NN	dobj
in	IN	prep
the	DT	det
stomach	NN	pobj
,	,	punct
upon	IN	prep
ingestion	NN	pobj
as	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
.	.	punct

yet	CC	cc
-PRON-	PRP$	poss
colleague	NNS	nsubj
,	,	punct
employ	VBG	advcl
-PRON-	PRP$	poss
own	JJ	amod
expertise	NN	dobj
,	,	punct
hold	VBP	ROOT
that	IN	mark
since	IN	mark
the	DT	det
scientist	NNS	nsubj
work	VBG	acl
in	IN	prep
this	DT	det
field	NN	pobj
turn	VBD	advcl
out	RP	prt
to	TO	aux
be	VB	auxpass
mistake	VBN	xcomp
,	,	punct
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
not	RB	neg
necessary	JJ	acomp
to	TO	aux
take	VB	xcomp
step	NNS	dobj
to	TO	aux
prevent	VB	relcl
acid	JJ	compound
degradation	NN	dobj
.	.	punct

the	DT	det
court	NN	nsubj
discount	VBZ	ROOT
the	DT	det
testimony	NN	dobj
of	IN	prep
the	DT	det
scientist	NNS	pobj
-PRON-	PRP	appos
,	,	punct
ignore	VBZ	conj
the	DT	det
knowledge	NN	dobj
concern	VBG	acl
this	DT	det
product	NN	dobj
and	CC	cc
-PRON-	PRP$	poss
instability	NN	conj
in	IN	prep
acid	NN	pobj
,	,	punct
ignore	VBZ	conj
the	DT	det
textbook	NN	compound
teaching	NNS	dobj
,	,	punct
and	CC	cc
find	VBZ	conj
that	IN	mark
this	DT	det
unlikely	JJ	amod
process	NN	nsubjpass
obviously	RB	advmod
should	MD	aux
have	VB	aux
be	VBN	auxpass
try	VBN	ccomp
.	.	punct

that	DT	nsubj
be	VBZ	ROOT
not	RB	neg
the	DT	det
law	NN	attr
of	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	

the	DT	det
statutory	JJ	amod
criterion	NN	nsubj
be	VBZ	ROOT
whether	IN	mark
the	DT	det
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	IN	prep
person	NNS	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
,	,	punct
not	RB	neg
whether	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
sufficiently	RB	advmod
simple	JJ	acomp
to	TO	aux
appear	VB	xcomp
obvious	JJ	oprd
to	IN	prep
judge	NNS	pobj
after	IN	mark
the	DT	det
discovery	NN	nsubjpass
be	VBZ	auxpass
finally	RB	advmod
make	VBN	advcl
,	,	punct
despite	IN	prep
the	DT	det
year	NNS	pobj
of	IN	prep
contrary	JJ	amod
belief	NN	pobj
among	IN	prep
the	DT	det
scientist	NNS	pobj
charge	VBN	acl
with	IN	prep
the	DT	det
project	NN	pobj
.	.	punct

At	IN	prep
the	DT	det
time	NN	pobj
that	WDT	mark
the	DT	det
Bayer	NNP	compound
scientist	NNS	nsubj
be	VBD	aux
attempt	VBG	relcl
to	TO	aux
formulate	VB	xcomp
drospirenone	NN	dobj
as	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
,	,	punct
the	DT	det
textbook	NN	compound
teaching	NN	nsubj
be	VBD	ROOT
that	IN	mark
micronize	VBG	amod
acid	NN	compound
-	HYPH	punct
sensitive	JJ	amod
product	NNS	nsubj
would	MD	aux
accelerate	VB	ccomp
-PRON-	PRP$	poss
acid	NN	npadvmod
-	HYPH	punct
induce	VBN	amod
degradation	NN	dobj
.	.	punct

see	VB	ROOT
,	,	punct
e.g.	RB	advmod
,	,	punct
Aulton	NNP	poss
's	POS	case
pharmaceutic	NNS	dobj
:	:	punct
the	DT	det
Design	NNP	appos
and	CC	cc
Manufacture	NNP	conj
of	IN	prep
Medicines	NNP	pobj
(	-LRB-	punct
advise	VBG	acl
against	IN	prep
micronize	VBG	pcomp
acid	NN	npadvmod
-	HYPH	punct
sensitive	JJ	amod
drug	NNS	dobj
because	IN	mark
-PRON-	PRP	nsubj
reduce	VBZ	advcl
the	DT	det
drug	NN	poss
's	POS	case
bioavailability	NN	dobj
)	-RRB-	punct
.	.	punct

-PRON-	PRP$	poss
colleague	NNS	nsubj
criticize	VBP	ROOT
these	DT	det
specialist	NNS	dobj
,	,	punct
and	CC	cc
rule	VB	conj
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
nonetheless	RB	advmod
obvious	JJ	acomp
to	TO	aux
conduct	VB	xcomp
experiment	NNS	dobj
that	IN	nsubj
-PRON-	PRP	nsubj
believe	VBD	relcl
would	MD	aux
not	RB	neg
work	VB	ccomp
.	.	punct

the	DT	det
court	NN	nsubj
rule	VBZ	ROOT
that	IN	mark
the	DT	det
scientist	NNS	nsubj
should	MD	aux
have	VB	aux
"	``	punct
try	VBN	ccomp
"	''	punct
that	IN	dobj
which	WDT	nsubj
-PRON-	PRP	nsubj
believe	VBD	relcl
would	MD	aux
fail	VB	ccomp
,	,	punct
and	CC	cc
that	IN	mark
when	WRB	advmod
-PRON-	PRP	nsubj
eventually	RB	advmod
do	VBD	aux
try	VB	advcl
this	DT	det
unlikely	JJ	amod
formulation	NN	dobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
succeed	VBD	conj
,	,	punct
-PRON-	PRP	nsubj
be	VBD	conj
obvious	JJ	acomp
to	TO	aux
do	VB	xcomp
so	RB	advmod
.	.	punct

 	_SP	

the	DT	det
unusual	JJ	amod
physiological	JJ	compound
behavior	NN	nsubjpass
of	IN	prep
drospirenone	NN	pobj
in	IN	prep
the	DT	det
stomach	NN	pobj
be	VBD	auxpass
not	RB	neg
know	VBN	ccomp
;	:	punct
this	DT	det
knowledge	NN	nsubj
follow	VBD	ccomp
as	IN	prep
scientific	JJ	amod
explanation	NN	pobj
;	:	punct
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
precede	VB	ROOT
the	DT	det
invention	NN	dobj
in	IN	prep
suit	NN	pobj
.	.	punct

there	EX	expl
be	VBD	ROOT
no	DT	det
evidence	NN	attr
to	TO	aux
reasonably	RB	advmod
suggest	VB	acl
that	IN	mark
micronized	JJ	amod
drospirenone	NN	nsubj
be	VBD	ccomp
likely	JJ	acomp
to	TO	aux
be	VB	xcomp
usable	JJ	acomp
,	,	punct
with	IN	prep
99	CD	nummod
+	CC	nummod
percent	NN	compound
consistency	NN	pobj
of	IN	prep
effectiveness	NN	pobj
,	,	punct
without	IN	prep
any	DT	det
protection	NN	pobj
from	IN	prep
degradation	NN	pobj
by	IN	prep
stomach	NN	compound
acid	NN	pobj
.	.	punct

a	DT	det
usable	JJ	amod
contraceptive	NN	nsubj
require	VBZ	ROOT
virtually	RB	advmod
complete	JJ	amod
effectiveness	NN	dobj
,	,	punct
and	CC	cc
the	DT	det
standard	NN	nsubj
confront	VBG	acl
the	DT	det
Bayer	NNP	compound
scientist	NNS	dobj
be	VBD	conj
high	JJ	acomp
.	.	punct

unlike	IN	prep
the	DT	det
unrelated	JJ	amod
drug	NNS	pobj
cite	VBN	acl
by	IN	agent
the	DT	det
panel	NN	compound
majority	NN	pobj
,	,	punct
contraceptive	NNS	nsubj
require	VBP	ROOT
complete	JJ	amod
effectiveness	NN	dobj
.	.	punct

previously	RB	advmod
know	VBN	amod
oral	JJ	amod
contraceptive	NNS	nsubj
such	JJ	amod
as	IN	prep
progesterone	NN	pobj
and	CC	cc
spironolactone	NN	conj
be	VBP	ROOT
not	RB	neg
acid	JJ	acomp
sensitive	JJ	acomp
,	,	punct
and	CC	cc
drospirenone	NN	nsubj
present	VBD	conj
a	DT	det
highly	RB	advmod
specific	JJ	amod
challenge	NN	dobj
to	IN	prep
the	DT	det
formulation	NN	compound
scientist	NNS	pobj
.	.	punct

the	DT	det
Bayer	NNP	compound
scientist	NNS	nsubj
believe	VBD	ROOT
that	IN	mark
the	DT	det
way	NN	nsubj
of	IN	prep
avoid	VBG	pcomp
the	DT	det
know	VBN	amod
acid	NN	compound
degradation	NN	dobj
of	IN	prep
drospirenone	NN	pobj
be	VBD	ccomp
to	TO	aux
protect	VB	xcomp
-PRON-	PRP	dobj
from	IN	prep
acid	NN	pobj
.	.	punct

-PRON-	PRP$	poss
colleague	NNS	nsubj
,	,	punct
however	RB	advmod
,	,	punct
find	VBP	ROOT
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	TO	aux
expose	VB	xcomp
-PRON-	PRP	dobj
to	IN	prep
acid	NN	pobj
,	,	punct
although	IN	mark
-PRON-	PRP	nsubj
be	VBD	advcl
not	RB	neg
obvious	JJ	acomp
to	IN	prep
the	DT	det
scientist	NNS	pobj
work	VBG	acl
on	IN	prep
the	DT	det
project	NN	pobj
.	.	punct

 	_SP	
"	``	punct
Obviousness	NNP	nsubj
"	''	punct
require	VBZ	ccomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
be	VBD	ccomp
obvious	JJ	acomp
to	IN	prep
person	NNS	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
field	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
.	.	punct

the	DT	det
law	NN	nsubj
do	VBZ	aux
not	RB	neg
hold	VB	ROOT
-PRON-	PRP	nsubj
"	``	punct
obvious	JJ	ccomp
to	TO	aux
try	VB	xcomp
"	''	punct
experiment	NNS	dobj
that	WDT	nsubj
contravene	VBP	relcl
conventional	JJ	amod
knowledge	NN	dobj
,	,	punct
and	CC	cc
that	DT	nsubjpass
be	VBP	auxpass
not	RB	neg
deem	VBN	conj
reasonably	RB	advmod
likely	JJ	oprd
to	TO	aux
succeed	VB	xcomp
.	.	punct

the	DT	det
evidence	NN	nsubj
in	IN	prep
this	DT	det
case	NN	pobj
be	VBZ	ROOT
a	DT	det
well	JJR	amod
measure	NN	attr
of	IN	prep
obviousness	JJ	pobj
than	IN	mark
be	VBZ	advcl
the	DT	det
hindsight	NN	compound
science	NN	nsubj
of	IN	prep
judge	NNS	pobj
,	,	punct
for	IN	prep
the	DT	det
scientist	NNS	pobj
who	WP	nsubj
eventually	RB	advmod
make	VBD	relcl
this	DT	det
discovery	NN	nsubj
testify	VBD	ccomp
,	,	punct
without	IN	prep
dispute	NN	pobj
,	,	punct
that	IN	mark
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
believe	VB	acl
an	DT	det
uncoated	JJ	amod
micronized	JJ	amod
product	NN	nsubj
would	MD	aux
meet	VB	ccomp
the	DT	det
demand	VBG	amod
criterion	NNS	dobj
of	IN	prep
contraceptive	JJ	amod
effectiveness	NN	pobj
.	.	punct

the	DT	det
Court	NNP	ROOT
in	IN	prep
KSR	NNP	compound
International	NNP	compound
Co.	NNP	pobj
v.	CC	prep
Teleflex	NNP	compound
Inc.	NNP	pobj
,	,	punct
550	CD	nummod
U.S.	NNP	appos
398	CD	nummod
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct

1727	CD	npadvmod
,	,	punct
167	CD	nummod
l.ed.2d	NN	nsubj
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
explain	VBD	ROOT
that	IN	mark
the	DT	det
standard	NN	nsubj
for	IN	prep
"	``	punct
obvious	JJ	pobj
to	TO	aux
try	VB	relcl
"	''	punct
be	VBZ	ccomp
whether	IN	mark
there	EX	expl
be	VBD	ccomp
a	DT	det
"	``	punct
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
"	''	punct
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
be	VBD	ROOT
undisputed	JJ	acomp
that	IN	mark
there	EX	expl
be	VBD	ccomp
not	RB	neg
.	.	punct

-PRON-	PRP	nsubj
be	VBD	ROOT
undisputed	JJ	acomp
that	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
not	RB	neg
reasonably	RB	advmod
expect	VBN	ccomp
that	IN	mark
uncoated	JJ	amod
micronized	JJ	amod
drospirenone	NN	nsubj
would	MD	aux
be	VB	ccomp
99+%	CD	nummod
effective	JJ	acomp
as	IN	prep
an	DT	det
oral	JJ	amod
contraceptive	NN	pobj
when	WRB	advmod
ingest	VBN	advcl
into	IN	prep
the	DT	det
acidic	JJ	amod
stomach	NN	pobj
,	,	punct
when	WRB	advmod
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	advcl
to	TO	aux
degrade	VB	xcomp
rapidly	RB	advmod
in	IN	prep
acid	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
micronization	NN	nsubj
be	VBD	ccomp
a	DT	det
"	``	punct
viable	JJ	amod
"	''	punct
option	NN	attr
,	,	punct
and	CC	cc
that	IN	mark
although	IN	mark
success	NN	nsubj
be	VBD	advcl
"	``	punct
uncertain	JJ	acomp
,	,	punct
"	''	punct
the	DT	det
invention	NN	nsubj
be	VBD	conj
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
.	.	punct

however	RB	advmod
,	,	punct
"	``	punct
viability	NN	nsubj
"	''	punct
be	VBZ	ccomp
not	RB	neg
the	DT	det
standard	NN	attr
.	.	punct
"	``	punct
viability	NN	nsubj
"	''	punct
imply	VBZ	ROOT
that	IN	mark
the	DT	det
experiment	NN	nsubj
may	MD	ccomp
or	CC	cc
may	MD	aux
not	RB	neg
succeed	VB	conj
.	.	punct

what	WP	dobj
the	DT	det
law	NN	nsubj
require	VBZ	csubj
be	VBZ	ROOT
not	RB	neg
guesswork	NN	attr
,	,	punct
not	RB	neg
dumb	JJ	amod
luck	NN	conj
,	,	punct
but	CC	cc
a	DT	det
reasonable	JJ	amod
degree	NN	conj
of	IN	prep
predictability	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

-PRON-	PRP$	poss
colleague	NNS	nsubj
depart	VBP	ROOT
from	IN	prep
the	DT	det
statutory	JJ	amod
standard	NN	pobj
,	,	punct
in	IN	prep
rule	VBG	pcomp
that	IN	mark
person	NNS	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
would	MD	aux
have	VB	aux
conduct	VBN	ccomp
experiment	NNS	dobj
that	WDT	nsubjpass
be	VBD	auxpass
expect	VBN	relcl
to	TO	aux
fail	VB	xcomp
.	.	punct

Nothing	NN	nsubj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
teach	VBZ	ccomp
the	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
of	IN	prep
ingestion	NN	pobj
of	IN	prep
uncoated	JJ	amod
micronized	JJ	amod
drospirenone	NN	pobj
;	:	punct
what	WP	nsubjpass
be	VBZ	auxpass
teach	VBN	csubj
be	VBZ	ROOT
the	DT	det
likelihood	NN	attr
of	IN	prep
failure	NN	pobj
.	.	punct

 	_SP	

the	DT	det
invention	NN	nsubjpass
must	MD	aux
be	VB	auxpass
view	VBN	ROOT
as	IN	prep
a	DT	det
whole	NN	pobj
.	.	punct

With	IN	prep
the	DT	det
exist	VBG	amod
knowledge	NN	pobj
that	IN	nsubj
drospirenone	NN	relcl
be	VBZ	ccomp
both	CC	dep
hydrophobic	JJ	acomp
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
degrade	VBZ	conj
rapidly	RB	advmod
in	IN	prep
acid	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
exist	VBG	amod
knowledge	NN	nsubj
that	DT	nsubj
micronization	NN	relcl
,	,	punct
although	IN	mark
useful	JJ	amod
to	TO	aux
counteract	VB	xcomp
a	DT	det
drug	NN	poss
's	POS	case
hydrophobic	NN	compound
property	NNS	dobj
,	,	punct
render	VBZ	conj
the	DT	det
drug	NN	dobj
even	RB	advmod
more	RBR	advmod
susceptible	JJ	ccomp
to	IN	prep
acid	JJ	compound
degradation	NN	pobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
not	RB	neg
show	VBN	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
this	DT	det
field	NN	pobj
would	MD	aux
have	VB	aux
have	VBN	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
achieve	VBG	pcomp
complete	JJ	amod
contraceptive	JJ	amod
bioavailability	NN	dobj
and	CC	cc
effectiveness	NN	conj
with	IN	prep
uncoated	JJ	amod
micronized	JJ	amod
drospirenone	NN	pobj
.	.	punct

the	DT	det
contrary	JJ	amod
view	NN	nsubj
have	VBZ	aux
surface	VBN	ROOT
only	RB	advmod
in	IN	prep
this	DT	det
litigation	NN	npadvmod
-	HYPH	punct
induce	VBN	amod
argument	NN	pobj
.	.	punct

the	DT	det
exercise	NN	nsubj
of	IN	prep
judicial	JJ	amod
expertise	NN	pobj
to	TO	aux
override	VB	acl
the	DT	det
clear	JJ	amod
evidence	NN	dobj
of	IN	prep
how	WRB	advmod
person	NNS	nsubj
of	IN	prep
skill	NN	pobj
in	IN	prep
this	DT	det
field	NN	pobj
actually	RB	advmod
behave	VBD	pcomp
,	,	punct
be	VBZ	ROOT
inappropriate	JJ	acomp
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
respectfully	RB	advmod
dissent	NN	ROOT
.	.	punct

 	_SP	

all	DT	det
Citations	NNPS	ROOT

 	_SP	
575	CD	nummod
f.3d	CD	appos
1341	CD	appos
,	,	punct
91	CD	nummod
U.S.P.Q.2d	NNS	appos
1569	CD	npadvmod

 	_SP	

